The present technology relates to semiconductor processes and equipment. More specifically, the present technology relates to cleaning or etching high-aspect-ratio structures.
Integrated circuits are made possible by processes which produce intricately patterned material layers on substrate surfaces. Producing patterned material on a substrate requires controlled methods for removal of exposed material. Chemical etching is used for a variety of purposes including transferring a pattern in photoresist into underlying layers, thinning layers, or thinning lateral dimensions of features already present on the surface. Often it is desirable to have an etch process that etches one material faster than another facilitating, for example, a pattern transfer process. Such an etch process is said to be selective to the first material. As a result of the diversity of materials, circuits, and processes, etch processes have been developed with a selectivity towards a variety of materials.
Etch processes may be termed wet or dry based on the materials used in the process. A wet HF etch preferentially removes silicon oxide over other dielectrics and materials. However, wet processes may have difficulty penetrating some constrained trenches and also may sometimes deform the remaining material. Dry etches produced in local plasmas formed within the substrate processing region can penetrate more constrained trenches and exhibit less deformation of delicate remaining structures. However, local plasmas may damage the substrate through the production of electric arcs as they discharge.
Thus, there is a need for improved systems and methods that can be used to produce high quality devices and structures. These and other needs are addressed by the present technology.
Exemplary cleaning, removal, and etching methods may include flowing a fluorine-containing precursor into a remote plasma region of a semiconductor processing chamber. The methods may include forming a plasma within the remote plasma region to generate plasma effluents of the fluorine-containing precursor. The methods may also include flowing the plasma effluents into a processing region of the semiconductor processing chamber. A substrate may be positioned within the processing region, and the substrate may include a region of exposed oxide. The methods may also include providing a hydrogen-containing precursor to the processing region. The methods may further include removing at least a portion of the exposed oxide while maintaining a relative humidity within the processing region below about 50%. Subsequent to the removal, the methods may include increasing the relative humidity within the processing region to greater than or about 50%. The methods may further include removing an additional amount of the exposed oxide.
Exemplary methods may also include continuing to flow the plasma effluents into the processing region while increasing the relative humidity within the processing region. A flow rate of the plasma effluents may be reduced while increasing the relative humidity within the processing region. In embodiments, a temperature of the substrate may be reduced while increasing the relative humidity within the processing region. For example, the temperature may be reduced by at least about 5° C. In embodiments a pressure within the processing chamber may be increased while increasing the relative humidity within the processing region. For example, the pressure may be increased by at least about 1 Torr. The relative humidity may be increased above about 65% in some embodiments. After methods according to the present technology have been performed including removal of an additional amount of exposed oxide, a concentration of fluorine in the substrate may be below or about 5%. Similarly, a concentration of oxygen in the substrate may be below or about 8%. In some embodiments, the hydrogen-containing precursor may bypass the remote plasma region when provided to the processing region. In some embodiments, the processing region may be maintained plasma free during the removing operations. Additionally, the relative humidity may be increased incrementally during exemplary methods, and may be increased incrementally by less than or about 20% per increment.
The present technology also encompasses cleaning methods. The methods may include flowing a fluorine-containing precursor into a remote plasma region of a semiconductor processing chamber while forming a plasma within the remote plasma region to generate plasma effluents of the fluorine-containing precursor. The methods may include flowing the plasma effluents into a processing region of the semiconductor processing chamber. The processing region may house or contain a substrate that may include a high-aspect-ratio feature having a region of exposed oxide. While flowing the plasma effluents into the processing region, the methods may include providing a hydrogen-containing precursor to the processing region. The methods may include removing at least a portion of the exposed oxide while maintaining a relative humidity within the processing region at greater than or about 50%. The methods may further include, subsequent the removing at least a portion of the exposed oxide, increasing a flow rate of the fluorine-containing precursor while maintaining the relative humidity within the processing region at greater than or about 50%. The methods may also include removing an additional amount of the exposed oxide.
In embodiments removing an additional amount of the exposed oxide may lower a concentration of oxygen by at least about 5%. In exemplary methods, the flow rate of the fluorine-containing precursor may be increased by at least about 2 sccm. In embodiments, a thickness of the exposed region of oxide prior to the removal operations may be less than or about 2 nm. Additionally, in some embodiments, a critical dimension of the high-aspect-ratio feature may be reduced by less than or about 1%.
The present technology also encompasses removal methods. The methods may include flowing a fluorine-containing precursor into a remote plasma region of a semiconductor processing chamber while forming a plasma within the remote plasma region to generate plasma effluents of the fluorine-containing precursor. The methods may include flowing the plasma effluents into a processing region of the semiconductor processing chamber. The processing region may house a substrate, which may have one or more high-aspect-ratio features having a region of exposed oxide. While flowing the plasma effluents into the processing region, the methods may include providing a hydrogen-containing precursor to the processing region. The methods may include continuing to flow the plasma effluents and the hydrogen-containing precursor into the processing region for at least about 200 seconds. The methods may also include removing at least a portion of the exposed oxide while maintaining a relative humidity within the processing region at greater than or about 50%. In some embodiments, the removing operation may reduce a surface-level concentration of oxygen within the substrate by at least about 3%.
Such technology may provide numerous benefits over conventional systems and techniques. For example, the processes may allow high-aspect-ratio features to be etched without developing pattern collapse. Additionally, the processes may allow a material removal to be performed while limiting a surface contamination level of a substrate. These and other embodiments, along with many of their advantages and features, are described in more detail in conjunction with the below description and attached figures.
A further understanding of the nature and advantages of the disclosed technology may be realized by reference to the remaining portions of the specification and the drawings.
Several of the figures are included as schematics. It is to be understood that the figures are for illustrative purposes, and are not to be considered of scale unless specifically stated to be of scale. Additionally, as schematics, the figures are provided to aid comprehension and may not include all aspects or information compared to realistic representations, and may include additional or exaggerated material for illustrative purposes.
In the appended figures, similar components and/or features may have the same reference label. Further, various components of the same type may be distinguished by following the reference label by a letter that distinguishes among the similar components. If only the first reference label is used in the specification, the description is applicable to any one of the similar components having the same first reference label irrespective of the letter.
Diluted acids may be used in many different semiconductor processes for cleaning substrates, and removing materials from those substrates. For example, diluted hydrofluoric acid can be an effective etchant for silicon oxide, and may be used to remove silicon oxide from silicon surfaces. After the etching or cleaning operation is complete, the acid may be dried from the wafer or substrate surface. Using dilute hydrofluoric acid (“DHF”) may be termed a “wet” etch, and the diluent is often water. Water has a relatively high surface tension that may act on the surfaces with which it is in contact.
Device patterning and features that continue to shrink in dimension may include delicate features etched or formed on a substrate. For example, many processing operations may work upon or form trenches, holes, or other features in a substrate or materials on a substrate. The aspect ratio, defined as the height to width ratio, may be very high in devices, and can be on the order of 5, 10, 20, 50, 100 or greater. Many of these features may have not only high aspect ratios, but also reduced dimensions on the scale of a few nanometers, for example, such that the critical dimensions across the substrate—often the width or dimension of these features—may be less than 10 nm, less than 5 nm, less than 3 nm, less than 2 nm, less than 1 nm, or even smaller. For example, the width of any particular column or wall between two trenches may be of only a few nanometers. The thinner is this material, the more impact stresses may pose on the integrity of the structure. Additionally, the material composing the structure may also impact the effect of exerted pressures or stresses on the material, be it a substrate material, dielectric, photo-resist, etc.
Issues may arise when delicate, high-aspect-ratio features are cleaned, etched, or processed, because the fluids may exhibit surface tensions that may be much higher than can be managed by the features. In designs having multiple features, layers, or materials, even a small amount of feature deformation or collapse can cause short circuits through the produced device rendering it inoperable. For example, although DHF may work well on low aspect ratio structures, when used as an etchant on high-aspect-ratio features, when the etching operation is finished and the DHF is dried or removed, the surface tension imposed on the features during the drying may cause pattern collapse. As device features continue to shrink, wet etching may no longer be sufficient because of its effect on high-aspect-ratio features. One promising technology for fluid removal in cleaning operations is by performing drying operations with super-critical fluids. Although these techniques may provide surfaces that are drier and less prone to pattern collapse, the amount of preparation, hardware requirements, and the number of operations involved may reduce the efficiency of overall substrate processing.
The present technology overcomes these issues by performing a dry etch process that provides adequate selectivity for the removal of silicon oxide relative to silicon, while maintaining high-aspect-ratio structures. The technology utilizes plasma enhanced precursors, which may include fluorine-containing precursors, to remove exposed regions of silicon oxide from silicon surfaces. By utilizing non-liquid materials, the effect on substrate features may be minimized. The term “dry” with respect to etching may be utilized to mean that liquid water may not be used in the operations, unlike with wet etches in which water may be used as a diluent or component, such as with DHF.
Although the remaining disclosure will routinely identify specific etching processes utilizing the disclosed technology, it will be readily understood that the systems and methods are equally applicable to deposition and cleaning processes as may occur in the described chambers. Accordingly, the technology should not be considered to be so limited as for use with etching processes or chambers alone. Moreover, although an exemplary chamber is described to provide foundation for the present technology, it is to be understood that the present technology can be applied to virtually any semiconductor processing chamber that may allow the operations described.
The substrate processing chambers 108a-f may include one or more system components for depositing, annealing, curing and/or etching a dielectric film on the substrate wafer. In one configuration, two pairs of the processing chambers, e.g., 108c-d and 108e-f, may be used to deposit dielectric material on the substrate, and the third pair of processing chambers, e.g., 108a-b, may be used to etch the deposited dielectric. In another configuration, all three pairs of chambers, e.g., 108a-f, may be configured to etch a dielectric film on the substrate. Any one or more of the processes described may be carried out in chamber(s) separated from the fabrication system shown in different embodiments. It will be appreciated that additional configurations of deposition, etching, annealing, and curing chambers for dielectric films are contemplated by system 100.
A cooling plate 203, faceplate 217, ion suppressor 223, showerhead 225, and a substrate support 265, having a substrate 255 disposed thereon, are shown and may each be included according to embodiments. The pedestal 265 may have a heat exchange channel through which a heat exchange fluid flows to control the temperature of the substrate, which may be operated to heat and/or cool the substrate or wafer during processing operations. The wafer support platter of the pedestal 265, which may comprise aluminum, ceramic, or a combination thereof, may also be resistively heated in order to achieve relatively high temperatures, such as from up to or about 100° C. to above or about 1100° C., using an embedded resistive heater element.
The faceplate 217 may be pyramidal, conical, or of another similar structure with a narrow top portion expanding to a wide bottom portion. The faceplate 217 may additionally be flat as shown and include a plurality of through-channels used to distribute process gases. Plasma generating gases and/or plasma excited species, depending on use of the RPS 201, may pass through a plurality of holes, shown in
Exemplary configurations may include having the gas inlet assembly 205 open into a gas supply region 258 partitioned from the first plasma region 215 by faceplate 217 so that the gases/species flow through the holes in the faceplate 217 into the first plasma region 215. Structural and operational features may be selected to prevent significant backflow of plasma from the first plasma region 215 back into the supply region 258, gas inlet assembly 205, and fluid supply system 210. The faceplate 217, or a conductive top portion of the chamber, and showerhead 225 are shown with an insulating ring 220 located between the features, which allows an AC potential to be applied to the faceplate 217 relative to showerhead 225 and/or ion suppressor 223. The insulating ring 220 may be positioned between the faceplate 217 and the showerhead 225 and/or ion suppressor 223 enabling a capacitively coupled plasma (CCP) to be formed in the first plasma region. A baffle (not shown) may additionally be located in the first plasma region 215, or otherwise coupled with gas inlet assembly 205, to affect the flow of fluid into the region through gas inlet assembly 205.
The ion suppressor 223 may comprise a plate or other geometry that defines a plurality of apertures throughout the structure that are configured to suppress the migration of ionically-charged species out of the first plasma region 215 while allowing uncharged neutral or radical species to pass through the ion suppressor 223 into an activated gas delivery region between the suppressor and the showerhead. In embodiments, the ion suppressor 223 may comprise a perforated plate with a variety of aperture configurations. These uncharged species may include highly reactive species that are transported with less reactive carrier gas through the apertures. As noted above, the migration of ionic species through the holes may be reduced, and in some instances completely suppressed. Controlling the amount of ionic species passing through the ion suppressor 223 may advantageously provide increased control over the gas mixture brought into contact with the underlying wafer substrate, which in turn may increase control of the deposition and/or etch characteristics of the gas mixture. For example, adjustments in the ion concentration of the gas mixture can significantly alter its etch selectivity, e.g., SiNx:SiOx etch ratios, Si:SiOx etch ratios, etc. In alternative embodiments in which deposition is performed, it can also shift the balance of conformal-to-flowable style depositions for dielectric materials.
The plurality of apertures in the ion suppressor 223 may be configured to control the passage of the activated gas, i.e., the ionic, radical, and/or neutral species, through the ion suppressor 223. For example, the aspect ratio of the holes, or the hole diameter to length, and/or the geometry of the holes may be controlled so that the flow of ionically-charged species in the activated gas passing through the ion suppressor 223 is reduced. The holes in the ion suppressor 223 may include a tapered portion that faces the plasma excitation region 215, and a cylindrical portion that faces the showerhead 225. The cylindrical portion may be shaped and dimensioned to control the flow of ionic species passing to the showerhead 225. An adjustable electrical bias may also be applied to the ion suppressor 223 as an additional means to control the flow of ionic species through the suppressor.
The ion suppressor 223 may function to reduce or eliminate the amount of ionically charged species traveling from the plasma generation region to the substrate. Uncharged neutral and radical species may still pass through the openings in the ion suppressor to react with the substrate. It should be noted that the complete elimination of ionically charged species in the reaction region surrounding the substrate may not be performed in embodiments. In certain instances, ionic species are intended to reach the substrate in order to perform the etch and/or deposition process. In these instances, the ion suppressor may help to control the concentration of ionic species in the reaction region at a level that assists the process.
Showerhead 225 in combination with ion suppressor 223 may allow a plasma present in first plasma region 215 to avoid directly exciting gases in substrate processing region 233, while still allowing excited species to travel from chamber plasma region 215 into substrate processing region 233. In this way, the chamber may be configured to prevent the plasma from contacting a substrate 255 being etched. This may advantageously protect a variety of intricate structures and films patterned on the substrate, which may be damaged, dislocated, or otherwise warped if directly contacted by a generated plasma. Additionally, when plasma is allowed to contact the substrate or approach the substrate level, the rate at which oxide species etch may increase. Accordingly, if an exposed region of material is oxide, this material may be further protected by maintaining the plasma remotely from the substrate.
The processing system may further include a power supply 240 electrically coupled with the processing chamber to provide electric power to the faceplate 217, ion suppressor 223, showerhead 225, and/or pedestal 265 to generate a plasma in the first plasma region 215 or processing region 233. The power supply may be configured to deliver an adjustable amount of power to the chamber depending on the process performed. Such a configuration may allow for a tunable plasma to be used in the processes being performed. Unlike a remote plasma unit, which is often presented with on or off functionality, a tunable plasma may be configured to deliver a specific amount of power to the plasma region 215. This in turn may allow development of particular plasma characteristics such that precursors may be dissociated in specific ways to enhance the etching profiles produced by these precursors.
A plasma may be ignited either in chamber plasma region 215 above showerhead 225 or substrate processing region 233 below showerhead 225. Plasma may be present in chamber plasma region 215 to produce the radical precursors from an inflow of, for example, a fluorine-containing precursor or other precursor. An AC voltage typically in the radio frequency (RF) range may be applied between the conductive top portion of the processing chamber, such as faceplate 217, and showerhead 225 and/or ion suppressor 223 to ignite a plasma in chamber plasma region 215 during deposition. An RF power supply may generate a high RF frequency of 13.56 MHz but may also generate other frequencies alone or in combination with the 13.56 MHz frequency.
The gas distribution assemblies such as showerhead 225 for use in the processing chamber section 200 may be referred to as dual channel showerheads (DCSH) and are additionally detailed in the embodiments described in
The showerhead 225 may comprise an upper plate 214 and a lower plate 216. The plates may be coupled with one another to define a volume 218 between the plates. The coupling of the plates may be so as to provide first fluid channels 219 through the upper and lower plates, and second fluid channels 221 through the lower plate 216. The formed channels may be configured to provide fluid access from the volume 218 through the lower plate 216 via second fluid channels 221 alone, and the first fluid channels 219 may be fluidly isolated from the volume 218 between the plates and the second fluid channels 221. The volume 218 may be fluidly accessible through a side of the gas distribution assembly 225.
The chambers discussed previously may be used in performing exemplary methods including etching methods. Turning to
The method 400 may include flowing a fluorine-containing precursor into a remote plasma region of a semiconductor processing chamber at operation 405. An exemplary chamber may be chamber 200 previously described, which may include one or both of the RPS unit 201 or first plasma region 215. Either or both of these regions may be the remote plasma region used in operation 405. A plasma may be generated within the remote plasma region at operation 410, which may generate plasma effluents of the fluorine-containing precursor. The plasma effluents may be flowed to a processing region of the chamber at operation 415. The plasma effluents may interact with the substrate in the processing region, which may include a trench or other feature formed through a semiconductor substrate, which may include silicon, germanium, or any other substrate or combination of elements as would be understood.
The substrate may include a region of exposed oxygen, which may be from one or more sources. For example, the oxygen may be an oxygen hardmask that remains after trenches or other features have been formed. The oxide may also be or include a layer of oxide that has formed from exposure of the substrate to air. For example, when a silicon substrate is exposed to air or some other oxygen source, a thin layer of oxide may form on the substrate. At operation 420, a hydrogen-containing precursor may be provided to the processing region along with the plasma effluents. The plasma effluents and hydrogen-containing precursor may interact with the exposed oxide to remove at least a portion of the exposed oxide at operation 425. During the removal, the relative humidity within the processing region may be maintained below or about 50%.
After a portion of the oxide has been removed at operation 425, the relative humidity within the processing region may be increased to greater than or about 50% at operation 430. While increasing the relative humidity, the plasma effluents may be continued to be flowed into the processing region in some embodiments. An additional amount of the exposed oxide may then be removed at operation 435. By increasing the relative humidity within the processing region during the removal, an additional amount of oxide may be removed that may allow additional benefits of the process that will be described further below.
Precursors used in the method may include a fluorine-containing precursor or a halogen-containing precursor. An exemplary fluorine-containing precursor may be nitrogen trifluoride (NF3), which may be flowed into the remote plasma region, which may be separate from, but fluidly coupled with, the processing region. Other sources of fluorine may be used in conjunction with or as replacements for the nitrogen trifluoride. In general, a fluorine-containing precursor may be flowed into the remote plasma region and the fluorine-containing precursor may include at least one precursor selected from the group of atomic fluorine, diatomic fluorine, nitrogen trifluoride, carbon tetrafluoride, hydrogen fluoride, xenon difluoride, and various other fluorine-containing precursors used or useful in semiconductor processing. The precursors may also include any number of carrier gases, which may include nitrogen, helium, argon, or other noble, inert, or useful precursors.
The hydrogen-containing precursor may include hydrogen, a hydrocarbon, water, hydrogen peroxide, or other materials that may include hydrogen as would be understood by the skilled artisan. Additional precursors such as carrier gases or inert materials may be included with the secondary precursors as well. One or more of the precursors may bypass the remote plasma region and be flowed into additional regions of the processing chamber. These precursors may be mixed with the plasma effluents in the processing region or some other region of the chamber. For example, while the fluorine-containing precursor is flowed through the remote plasma region to produce fluorine-containing plasma effluents, the hydrogen-containing precursor may bypass the remote plasma region. The hydrogen-containing precursor may bypass the remote plasma region by a bypass at a top of the chamber, or may be flowed into a separate region of the chamber, such as through a port providing access to the volume within the showerhead, such as showerhead 225 of
Additional aspects of the present technology may be further understood with reference to
In the exemplary situation in which reactive-ion etching may have been used to form trench 510, an oxide hardmask 515 may be formed on a surface of the substrate 505. Additionally, residue material 520 may be formed or left within the trench 510, which may include carbon, oxygen, or other impurities from the etching. Operations of a process, such as selected operations of process 400 described previously, may be performed to remove the exposed oxide material from the surface of the silicon substrate 505. For example, a hydrogen-containing precursor and plasma effluents of a fluorine-containing precursor may be delivered to the processing region to at least partially remove the oxide hardmask 515 as well as the residue material 520. Because the trench 510 along with any other features may have high aspect ratios, the relative humidity within the processing region may be maintained below about 50% in embodiments. By maintaining the relative humidity below about 50%, water droplets may not form along the surfaces, which may cause pattern deformation or collapse when they are dried or removed.
After the oxide hardmask 515 and the residue material 520 have been removed, there may be a thin film of oxide remaining. As illustrated in
Dry etching operations that may include certain operations as described with respect to
Oxide material 525 may allow a surface-level concentration of fluorine within the substrate to increase. The fluorine contained within or attached to the oxide material 525 may be up to or greater than an atomic percent of 8% in certain regions of the substrate, such as a center region. A desired level of fluorine to minimize leakage current from this impurity may be below or about 3%, for example. Such a level of fluorine incorporation may be produced by wet etching, but as feature size is reduced, wet etching may cause pattern collapse and device failure. The present technology, however, may utilize relative humidity and/or one or more other conditions discussed below to reduce the surface-level concentration of fluorine below other dry etch processes.
As described previously with
Additionally, the oxide hardmask during removal with a dry etchant may produce silicon fluoride. With water, however, fluorosilicic acid may be produced from the oxide hardmask which may cause pattern collapse due to a relatively tacky consistency. Accordingly, when an oxide hardmask is being removed, the operations may be performed at lower relative humidity, such as about 25% relative humidity, for example, to remove the majority of the hardmask material. In other embodiments, the relative humidity may be maintained below or about 50%, below or about 45%, below or about 40%, below or about 35%, below or about 30%, below or about 25%, below or about 20% below or about 15%, below or about 10%, or lower. The relative humidity may also be maintained between any of these numbers, or at any smaller range included within these ranges.
When the remaining oxide material has been reduced sufficiently, such as below a threshold of a few nanometers or less, or when the etching operation may not remove additional oxide material, the relative humidity may be increased above about 50%. The increased relative humidity may allow additional oxygen to be removed, and allow fluorine that may be associated or attached to the oxide to me removed as well. The relative humidity may be increased above or about 50% in embodiments, and may also be increased above or about 55%, above or about 60% above or about 65%, above or about 70%, above or about 75%, above or about 80%, above or about 85%, above or about 90%, above or about 95%, or higher, although at 100% relative humidity liquid water may be present, which may cause pattern collapse or deformation. Accordingly, the relative humidity may be maintained below or about 100%, between any of the other stated percentages, or within any smaller range within the stated ranges.
As illustrated in
Turning to
Process conditions may also impact the operations performed in method 400 as well as other removal methods according to the present technology. Each of the operations of method 400 may be performed during a constant temperature in embodiments, while in some embodiments the temperature may be adjusted during different operations. For example, the substrate, pedestal, or chamber temperature during the method 400 may be maintained below or about 50° C. in embodiments. The substrate temperature may also be maintained below or about 45° C., below or about 40° C., below or about 35° C., below or about 30° C., below or about 25° C., below or about 20° C., below or about 15° C., below or about 10° C., below or about 5° C., below or about 0° C., below or about −5° C., or lower. In some embodiments, however, the temperature may be maintained above or about 0° C. to prevent the hydrogen-containing precursor, which may be water, from freezing. The temperature may also be maintained at any temperature within these ranges, within smaller ranges encompassed by these ranges, or between any of these ranges.
In some embodiments the first removal operation 425 may be performed at a first temperature, while the additional removal operation 435 may be performed at a second temperature. Either or both of the temperatures may be within any of the ranges previously described. The second temperature may be lower than the first temperature in embodiments. For example, during the relative humidity increase, the temperature of the substrate may be lowered from the first temperature to the second temperature. By lowering the temperature of the substrate, the relative humidity at the wafer level may also be increased without adding substantially more water vapor to the processing chamber. The opportunity for water droplets to form on the chamber components or on the substrate may then be reduced, which may aid in reducing or preventing pattern deformation or collapse.
For example, the first temperature may be greater than or about 10° C., and the second temperature may be less than or about 10° C. in embodiments. In some embodiments, the first temperature may be between about 10° C. and about 20° C., between about 11° C. and about 18° C., between about 12° C. and about 15° C., or may be about 12° C., about 13° C., about 14° C., or about 15° C. in embodiments. Additionally, in embodiments the second temperature may be between about 0° C. and about 10° C., between about 1° C. and about 8° C., between about 2° C. and about 5° C., or may be about 2° C., about 3° C., about 4° C., or about 5° C. in embodiments. The temperature reduction between the first temperature and the second temperature may be at least about 2° C. in embodiments, and may be at least or about 3° C., at least or about 4° C., at least or about 5° C., at least or about 6° C., at least or about 7° C., at least or about 8° C., at least or about 9° C., at least or about 10° C., at least or about 11° C., at least or about 12° C., or more. Additionally, the temperature decrease may be less than or about 15° C., or any smaller range between any of these ranges or within any of these ranges.
The pressure within the chamber may also affect the operations performed, and in embodiments the chamber pressure may be maintained below about 50 Torr, below or about 40 Torr, below or about 30 Torr, below or about 25 Torr, below or about 20 Torr, below or about 15 Torr, below or about 10 Torr, below or about 5 Torr, below or about 1 Torr, or less. The pressure may also be maintained at any pressure within these ranges, within smaller ranges encompassed by these ranges, or between any of these ranges.
In some embodiments the first removal operation 425 may be performed at a first pressure, while the additional removal operation 435 may be performed at a second pressure. Either or both of the pressures may be within any of the ranges previously described. The second pressure may be higher than the first pressure in embodiments. For example, during the relative humidity increase, the pressure within the processing chamber may be increased from the first pressure to the second pressure. By increasing the pressure within the chamber, the relative humidity at the wafer level may also be increased without adding substantially more water vapor to the processing chamber. The opportunity for water droplets to form on the chamber components or on the substrate may then be reduced, which again may aid in reducing or preventing pattern deformation or collapse.
For example, the first pressure may be less than or about 10 Torr, and the second pressure may be greater than or about 10 Torr in embodiments. In some embodiments, the first pressure may be between about 0 Torr and about 10 Torr, between about 3 Torr and about 9 Torr, between about 5 Torr and about 8 Torr, or may be about 5 Torr, about 6 Torr, about 7 Torr, or about 8 Torr in embodiments. In embodiments, the second pressure may be between about 10 Torr and about 20 Torr, between about 10 Torr and about 18 Torr, between about 11 Torr and about 15 Torr, or may be about 11 Torr, about 12 Torr, about 13 Torr, about 14 Torr, or about 15 Torr. The pressure increase between the first pressure and the second pressure may be at least about 1 Torr in embodiments, and may be at least or about 2 Torr, at least or about 3 Torr, at least or about 4 Torr, at least or about 5 Torr, at least or about 6 Torr, at least or about 7 Torr, at least or about 8 Torr, or more in embodiments. The pressure increase may be less than or about 10 Torr in embodiments, or may be a smaller range within any of these ranges or between any of these ranges.
The flow rates of one or more of the precursors may also be adjusted with any of the other processing conditions. For example, a flow rate of the fluorine-containing precursor may be reduced while increasing the relative humidity within the processing region, although in some embodiments it may be maintained or increased. During any of the operations of method 400, the flow rate of the fluorine-containing precursor may be between about 2 sccm and about 100 sccm. Additionally, the flow rate of the fluorine-containing precursor may be at least or about 2 sccm, at least or about 3 sccm, at least or about 4 sccm, at least or about 5 sccm, at least or about 6 sccm, at least or about 7 sccm, at least or about 8 sccm, at least or about 9 sccm, at least or about 10 sccm, at least or about 11 sccm, at least or about 12 sccm, at least or about 13 sccm, at least or about 14 sccm, at least or about 15 sccm, at least or about 16 sccm, at least or about 17 sccm, at least or about 18 sccm, at least or about 19 sccm, at least or about 20 sccm, at least or about 25 sccm, at least or about 30 sccm, at least or about 40 sccm, at least or about 50 sccm, at least or about 60 sccm, at least or about 80 sccm, or more. The flow rate may also be between any of these stated flow rates, or within smaller ranges encompassed by any of these numbers.
The hydrogen-containing precursor may be flowed at any of these flow rates depending on the precursor used, which may be any number of hydrogen-containing precursors. For example, if water vapor is utilized, the water may be introduced at a rate of at least or about 1 g/min. The water may also be introduced at a rate of at least or about 2 g/min, at least or about 3 g/min, at least or about 4 g/min, at least or about 5 g/min, at least or about 6 g/min, at least or about 7 g/min, at least or about 8 g/min, at least or about 9 g/min, or more, although the water may be introduced below about 10 g/min to reduce water condensation on components and the substrate. The water may also be introduced at a flow rate between any of these stated flow rates, or within smaller ranges encompassed by any of these numbers.
At the completion of method 400, a concentration of fluorine in the substrate may be below or about 8% in embodiments, and may be below or about 7%, below or about 6%, below or about 5%, below or about 4%, below or about 3%, below or about 2%, below or about 1%, or less. Similarly, a concentration of oxygen in the substrate may be below or about 15% in embodiments, and may be below or about 12%, below or about 10%, below or about 9%, below or about 8%, below or about 7%, below or about 6%, below or about 5%, below or about 4%, below or about 3%, below or about 2%, below or about 1%, or less.
The increase in relative humidity may be performed incrementally in some embodiments. For example, the relative humidity may be increased a certain percentage while the precursors are delivered to the processing region. The relative humidity may be increased in one or more increments that may be less than or about 50% relative humidity, less than or about 40% relative humidity, less than or about 30% relative humidity, less than or about 20% relative humidity, less than or about 15% relative humidity, less than or about 10% relative humidity, less than or about 5% relative humidity, or less. The relative humidity may also be increased in increments between any of these values or within smaller ranges encompassed by any of these ranges. Additionally, the relative humidity may be gradually increased from a starting relative humidity to a final relative humidity in embodiments that may be performed over a period of time to reduce the opportunity for excessive water condensation to occur, which may lead to pattern deformation or collapse.
Turning to
While the plasma effluents are being flowed into the processing region, a hydrogen-containing precursor may be flowed into the processing region at operation 715. The hydrogen-containing precursor may bypass the remote plasma region in embodiments. At operation 720 at least a portion of the exposed oxide may be removed while maintaining a relative humidity within the processing region at greater than or about 50%. At operation 725, subsequent the at least partial removal, a flow rate of the fluorine-containing precursor may be increased while maintaining the relative humidity within the processing region at greater than or about 50%. Additional exposed oxide may be removed at operation 730.
The present technology may also be effective at producing the benefits described previously in conditions where the relative humidity may not be capable of increase above a threshold value. Additionally, in conjunction with the increase in relative humidity, the flow rate of the fluorine-containing precursor may be increased, which may further remove additional oxygen or fluorine materials. The method may include a threshold relative humidity value, such as at least about 50% relative humidity in order to provide the removal of materials as previously described. When the relative humidity is reduced below or about 50% for a residual oxide layer, bonds may be more difficult or incapable of cleaving as discussed above.
The removal operations may reduce the oxygen incorporation below about 14% in embodiments, and may lower the oxygen incorporation below or about 12%, below or about 10%, below or about 7%, below or about 6%, below or about 5%, below or about 4%, below or about 3%, below or about 2%, or less. The removal operations may also reduce the oxygen incorporation by at least or about 2%, and may reduce the oxygen incorporation by at least or about 3%, at least or about 4%, at least or about 5%, at least or about 6%, at least or about 7%, at least or about 8%, at least or about 9%, at least or about 10%, at least or about 11%, at least or about 12%, or more.
Method 700 may be performed on an oxide material, such as oxide material 525 as illustrated in
While the plasma effluents are being flowed into the processing region, a hydrogen-containing precursor may be flowed into the processing region at operation 920. The hydrogen-containing precursor may bypass the remote plasma region in embodiments. At operation 925 the precursors may be continuously flowed through the processing region for a period of time. At least a portion of the exposed oxide material may be removed during the precursor introduction at operation 930. During the removal, the relative humidity within the processing chamber may be maintained at greater than or about 50% as a threshold as described above.
Method 900 may also be effective at producing the benefits described previously in conditions where the relative humidity may not be capable of increase above a threshold value. Additionally, in conjunction with the increase in relative humidity and/or with an increase in fluorine-containing precursor flow rate, removal of oxide material may be performed over a period of time to further reduce the oxygen concentration at the substrate.
The previously discussed methods may allow the removal of oxide material from a substrate while limiting the fluorine incorporation, and while maintaining critical dimensions of the substrate features, which may be high-aspect-ratio features. The operations performed may include one or more of increasing the relative humidity during the removal, increasing the fluorine-containing precursor flow rate during the removal, or continuing the removal for a period of time as discussed. Additional chamber operations may also be adjusted as discussed throughout the present disclosure. By utilizing the present methods and operations, high-aspect-ratio features may be cleaned or etched while not causing pattern collapse unlike wet etching, and while not increasing or while limiting impurity inclusion such as fluorine, unlike some conventional dry etching.
In the preceding description, for the purposes of explanation, numerous details have been set forth in order to provide an understanding of various embodiments of the present technology. It will be apparent to one skilled in the art, however, that certain embodiments may be practiced without some of these details, or with additional details.
Having disclosed several embodiments, it will be recognized by those of skill in the art that various modifications, alternative constructions, and equivalents may be used without departing from the spirit of the embodiments. Additionally, a number of well-known processes and elements have not been described in order to avoid unnecessarily obscuring the present technology. Accordingly, the above description should not be taken as limiting the scope of the technology. Additionally, methods or processes may be described as sequential or in steps, but it is to be understood that the operations may be performed concurrently, or in different orders than listed.
Where a range of values is provided, it is understood that each intervening value, to the smallest fraction of the unit of the lower limit, unless the context clearly dictates otherwise, between the upper and lower limits of that range is also specifically disclosed. Any narrower range between any stated values or unstated intervening values in a stated range and any other stated or intervening value in that stated range is encompassed. The upper and lower limits of those smaller ranges may independently be included or excluded in the range, and each range where either, neither, or both limits are included in the smaller ranges is also encompassed within the technology, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included.
As used herein and in the appended claims, the singular forms “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise. Thus, for example, reference to “a precursor” includes a plurality of such precursors, and reference to “the layer” includes reference to one or more layers and equivalents thereof known to those skilled in the art, and so forth.
Also, the words “comprise(s)”, “comprising”, “contain(s)”, “containing”, “include(s)”, and “including”, when used in this specification and in the following claims, are intended to specify the presence of stated features, integers, components, or operations, but they do not preclude the presence or addition of one or more other features, integers, components, operations, acts, or groups.
Number | Name | Date | Kind |
---|---|---|---|
2369620 | Sullivan et al. | Feb 1945 | A |
3451840 | Hough | Jun 1969 | A |
3537474 | Rohrer | Nov 1970 | A |
3756511 | Shinroku | Sep 1973 | A |
3937857 | Brummett et al. | Feb 1976 | A |
3969077 | Hill | Jul 1976 | A |
4006047 | Brummett et al. | Feb 1977 | A |
4209357 | Gorin et al. | Jun 1980 | A |
4214946 | Forget et al. | Jul 1980 | A |
4232060 | Mallory, Jr. | Nov 1980 | A |
4234628 | DuRose | Nov 1980 | A |
4265943 | Goldstein et al. | May 1981 | A |
4340462 | Koch | Jul 1982 | A |
4341592 | Shortes et al. | Jul 1982 | A |
4361418 | Tscheppe | Nov 1982 | A |
4361441 | Tylko | Nov 1982 | A |
4364803 | Nidola et al. | Dec 1982 | A |
4368223 | Kobayashi et al. | Jan 1983 | A |
4374698 | Sanders et al. | Feb 1983 | A |
4397812 | Mallory, Jr. | Aug 1983 | A |
4468413 | Bachmann | Aug 1984 | A |
4565601 | Kakehi et al. | Jan 1986 | A |
4579618 | Celestino et al. | Apr 1986 | A |
4585920 | Hoog et al. | Apr 1986 | A |
4610775 | Phifer | Sep 1986 | A |
4625678 | Shloya et al. | Dec 1986 | A |
4632857 | Mallory, Jr. | Dec 1986 | A |
4656052 | Satou et al. | Apr 1987 | A |
4656076 | Vetanen et al. | Apr 1987 | A |
4668335 | Mockler | May 1987 | A |
4690746 | McInerney et al. | Sep 1987 | A |
4715937 | Moslehi et al. | Dec 1987 | A |
4749440 | Blackwood et al. | Jun 1988 | A |
4753898 | Parrillo et al. | Jun 1988 | A |
4786360 | Cote et al. | Nov 1988 | A |
4793897 | Dunfield et al. | Dec 1988 | A |
4807016 | Douglas | Feb 1989 | A |
4810520 | Wu | Mar 1989 | A |
4816638 | Ukai et al. | Mar 1989 | A |
4820377 | Davis et al. | Apr 1989 | A |
4828649 | Davis | May 1989 | A |
4857140 | Loewenstein | Aug 1989 | A |
4904621 | Loewenstein et al. | Feb 1990 | A |
4913929 | Moslehi et al. | Apr 1990 | A |
4946903 | Gardella et al. | Aug 1990 | A |
4951601 | Maydan et al. | Aug 1990 | A |
4960488 | Law et al. | Oct 1990 | A |
4980018 | Mu et al. | Dec 1990 | A |
4981551 | Palmour | Jan 1991 | A |
4985372 | Narita et al. | Jan 1991 | A |
4991542 | Kohmura et al. | Feb 1991 | A |
4992136 | Tachi et al. | Feb 1991 | A |
4994404 | Sheng et al. | Feb 1991 | A |
5000113 | Wang et al. | Mar 1991 | A |
5006192 | Deguchi | Apr 1991 | A |
5013691 | Lory et al. | May 1991 | A |
5028565 | Chang | Jul 1991 | A |
5030319 | Nishino et al. | Jul 1991 | A |
5038713 | Kawakami et al. | Aug 1991 | A |
5045244 | Marlett | Sep 1991 | A |
5061838 | Lane et al. | Oct 1991 | A |
5083030 | Stavov | Jan 1992 | A |
5089441 | Moslehi | Feb 1992 | A |
5089442 | Olmer | Feb 1992 | A |
5147692 | Bengston | Sep 1992 | A |
5156881 | Okano et al. | Oct 1992 | A |
5180435 | Markunas et al. | Jan 1993 | A |
5186718 | Tepman et al. | Feb 1993 | A |
5188706 | Hori et al. | Feb 1993 | A |
5198034 | deBoer et al. | Mar 1993 | A |
5203911 | Sricharoenchalkit et al. | Apr 1993 | A |
5215787 | Homma | Jun 1993 | A |
5228501 | Tepman et al. | Jul 1993 | A |
5231690 | Soma et al. | Jul 1993 | A |
5235139 | Bengston et al. | Aug 1993 | A |
5238499 | van de Ven et al. | Aug 1993 | A |
5240497 | Shacham et al. | Aug 1993 | A |
5248371 | Maher et al. | Sep 1993 | A |
5248527 | Uchida et al. | Sep 1993 | A |
5252178 | Moslehi | Oct 1993 | A |
5266157 | Kadomura | Nov 1993 | A |
5269881 | Sekiya | Dec 1993 | A |
5270125 | America et al. | Dec 1993 | A |
5271972 | Kwok et al. | Dec 1993 | A |
5275977 | Otsubo et al. | Jan 1994 | A |
5277750 | Frank | Jan 1994 | A |
5279669 | Lee | Jan 1994 | A |
5279865 | Chebi et al. | Jan 1994 | A |
5288518 | Homma | Feb 1994 | A |
5290382 | Zarowin et al. | Mar 1994 | A |
5292370 | Tsai et al. | Mar 1994 | A |
5292682 | Stevens et al. | Mar 1994 | A |
5300463 | Cathey et al. | Apr 1994 | A |
5302233 | Kim et al. | Apr 1994 | A |
5306530 | Strongin et al. | Apr 1994 | A |
5314724 | Tsukune et al. | May 1994 | A |
5319247 | Matsuura | Jun 1994 | A |
5326427 | Jerbic | Jul 1994 | A |
5328558 | Kawamura et al. | Jul 1994 | A |
5328810 | Lowrey et al. | Jul 1994 | A |
5330578 | Sakama | Jul 1994 | A |
5334552 | Homma | Aug 1994 | A |
5345999 | Hosokawa | Sep 1994 | A |
5352636 | Beinglass | Oct 1994 | A |
5356478 | Chen et al. | Oct 1994 | A |
5362526 | Wang et al. | Nov 1994 | A |
5368897 | Kurihara et al. | Nov 1994 | A |
5378316 | Franke et al. | Jan 1995 | A |
5380560 | Kaja et al. | Jan 1995 | A |
5382311 | Ishikawa et al. | Jan 1995 | A |
5384284 | Doan et al. | Jan 1995 | A |
5385763 | Okano et al. | Jan 1995 | A |
5399237 | Keswick et al. | Mar 1995 | A |
5399529 | Homma | Mar 1995 | A |
5403434 | Moslehi | Apr 1995 | A |
5413670 | Langan et al. | May 1995 | A |
5413967 | Matsuda et al. | May 1995 | A |
5415890 | Kloiber et al. | May 1995 | A |
5416048 | Blalock et al. | May 1995 | A |
5420075 | Homma et al. | May 1995 | A |
5429995 | Nishiyama et al. | Jul 1995 | A |
5439553 | Grant et al. | Aug 1995 | A |
5451259 | Krogh | Sep 1995 | A |
5464499 | Moslehi | Nov 1995 | A |
5468342 | Nulty et al. | Nov 1995 | A |
5474589 | Ohga et al. | Dec 1995 | A |
5478403 | Shinagawa et al. | Dec 1995 | A |
5478462 | Walsh | Dec 1995 | A |
5483920 | Pryor | Jan 1996 | A |
5500249 | Telford et al. | Mar 1996 | A |
5505816 | Barnes et al. | Apr 1996 | A |
5510216 | Calabrese et al. | Apr 1996 | A |
5516367 | Lei et al. | May 1996 | A |
5518962 | Murao | May 1996 | A |
5531835 | Fodor et al. | Jul 1996 | A |
5534070 | Okamura et al. | Jul 1996 | A |
5536360 | Nguyen et al. | Jul 1996 | A |
5549780 | Koinuma et al. | Aug 1996 | A |
5558717 | Zhao et al. | Sep 1996 | A |
5560779 | Knowles et al. | Oct 1996 | A |
5563105 | Dobuzinsky et al. | Oct 1996 | A |
5567243 | Foster et al. | Oct 1996 | A |
5571576 | Qian et al. | Nov 1996 | A |
5575853 | Arami et al. | Nov 1996 | A |
5578130 | Hayashi et al. | Nov 1996 | A |
5578161 | Auda | Nov 1996 | A |
5580421 | Hiatt et al. | Dec 1996 | A |
5591269 | Arami et al. | Jan 1997 | A |
5592358 | Shamouilian | Jan 1997 | A |
5599740 | Jang et al. | Feb 1997 | A |
5614055 | Fairbairn et al. | Mar 1997 | A |
5616518 | Foo et al. | Apr 1997 | A |
5624582 | Cain | Apr 1997 | A |
5626922 | Miyanaga et al. | May 1997 | A |
5628829 | Foster et al. | May 1997 | A |
5635086 | Warren, Jr. | Jun 1997 | A |
5645645 | Zhang et al. | Jul 1997 | A |
5648125 | Cane | Jul 1997 | A |
5648175 | Russell et al. | Jul 1997 | A |
5656093 | Burkhart et al. | Aug 1997 | A |
5660957 | Chou et al. | Aug 1997 | A |
5661093 | Ravi et al. | Aug 1997 | A |
5670066 | Barnes et al. | Sep 1997 | A |
5674787 | Zhao et al. | Oct 1997 | A |
5676758 | Hasgawa et al. | Oct 1997 | A |
5679606 | Wang et al. | Oct 1997 | A |
5685946 | Fathauer et al. | Nov 1997 | A |
5688331 | Aruga et al. | Nov 1997 | A |
5695810 | Dubin et al. | Dec 1997 | A |
5712185 | Tsai et al. | Jan 1998 | A |
5716500 | Bardos et al. | Feb 1998 | A |
5716506 | Maclay et al. | Feb 1998 | A |
5719085 | Moon et al. | Feb 1998 | A |
5733816 | Iyer et al. | Mar 1998 | A |
5747373 | Yu | May 1998 | A |
5753886 | Iwamura et al. | May 1998 | A |
5755859 | Brusic et al. | May 1998 | A |
5756400 | Ye et al. | May 1998 | A |
5756402 | Jimbo et al. | May 1998 | A |
5772770 | Suda et al. | Jun 1998 | A |
5781693 | Ballance et al. | Jul 1998 | A |
5786276 | Brooks et al. | Jul 1998 | A |
5788825 | Park et al. | Aug 1998 | A |
5789300 | Fulford | Aug 1998 | A |
5792376 | Kanai et al. | Aug 1998 | A |
5800686 | Littau et al. | Sep 1998 | A |
5804259 | Robles | Sep 1998 | A |
5812403 | Fong et al. | Sep 1998 | A |
5814238 | Ashby et al. | Sep 1998 | A |
5814365 | Mahawill | Sep 1998 | A |
5820723 | Benjamin et al. | Oct 1998 | A |
5824599 | Schacham-Diamand et al. | Oct 1998 | A |
5830805 | Shacham-Diamand et al. | Nov 1998 | A |
5835334 | McMillin et al. | Nov 1998 | A |
5843538 | Ehrsam et al. | Dec 1998 | A |
5843847 | Pu et al. | Dec 1998 | A |
5844195 | Fairbairn et al. | Dec 1998 | A |
5846332 | Zhao et al. | Dec 1998 | A |
5846373 | Pirkle et al. | Dec 1998 | A |
5846375 | Gilchrist et al. | Dec 1998 | A |
5846598 | Semkow et al. | Dec 1998 | A |
5849639 | Molloy et al. | Dec 1998 | A |
5850105 | Dawson et al. | Dec 1998 | A |
5855681 | Maydan et al. | Jan 1999 | A |
5855685 | Tobe et al. | Jan 1999 | A |
5856240 | Sinha et al. | Jan 1999 | A |
5858876 | Chew | Jan 1999 | A |
5865896 | Nowak | Feb 1999 | A |
5866483 | Shiau et al. | Feb 1999 | A |
5872052 | Iyer | Feb 1999 | A |
5872058 | Van Cleemput et al. | Feb 1999 | A |
5882424 | Taylor et al. | Mar 1999 | A |
5882786 | Nassau et al. | Mar 1999 | A |
5883012 | Chiou | Mar 1999 | A |
5885404 | Kim et al. | Mar 1999 | A |
5885749 | Huggins et al. | Mar 1999 | A |
5888906 | Sandhu et al. | Mar 1999 | A |
5891349 | Tobe et al. | Apr 1999 | A |
5891513 | Dubin et al. | Apr 1999 | A |
5897751 | Makowiecki | Apr 1999 | A |
5899752 | Hey et al. | May 1999 | A |
5900163 | Yi et al. | May 1999 | A |
5904827 | Reynolds | May 1999 | A |
5907790 | Kellam | May 1999 | A |
5910340 | Uchida et al. | Jun 1999 | A |
5913147 | Dubin et al. | Jun 1999 | A |
5915190 | Pirkle | Jun 1999 | A |
5918116 | Chittipeddi | Jun 1999 | A |
5920792 | Lin | Jul 1999 | A |
5926737 | Ameen et al. | Jul 1999 | A |
5932077 | Reynolds | Aug 1999 | A |
5933757 | Yoshikawa et al. | Aug 1999 | A |
5935334 | Fong et al. | Aug 1999 | A |
5937323 | Orczyk et al. | Aug 1999 | A |
5939831 | Fong et al. | Aug 1999 | A |
5942075 | Nagahata et al. | Aug 1999 | A |
5944049 | Beyer et al. | Aug 1999 | A |
5944902 | Redeker et al. | Aug 1999 | A |
5948702 | Rotondaro | Sep 1999 | A |
5951601 | Lesinski et al. | Sep 1999 | A |
5951776 | Selyutin et al. | Sep 1999 | A |
5951896 | Mahawill | Sep 1999 | A |
5953591 | Ishihara et al. | Sep 1999 | A |
5953635 | Andideh | Sep 1999 | A |
5968610 | Liu et al. | Oct 1999 | A |
5969422 | Ting et al. | Oct 1999 | A |
5976327 | Tanaka | Nov 1999 | A |
5990000 | Hong et al. | Nov 1999 | A |
5990013 | Berenguer et al. | Nov 1999 | A |
5993916 | Zhao et al. | Nov 1999 | A |
5997962 | Ogasawara et al. | Dec 1999 | A |
6004884 | Abraham | Dec 1999 | A |
6007635 | Mahawill | Dec 1999 | A |
6007785 | Liou | Dec 1999 | A |
6010962 | Liu et al. | Jan 2000 | A |
6013191 | Nasser-Faili et al. | Jan 2000 | A |
6013584 | M'Saad | Jan 2000 | A |
6015724 | Yamazaki et al. | Jan 2000 | A |
6015747 | Lopatin et al. | Jan 2000 | A |
6017414 | Koemtzopoulos et al. | Jan 2000 | A |
6020271 | Yanagida | Feb 2000 | A |
6030666 | Lam et al. | Feb 2000 | A |
6030881 | Papasouliotis et al. | Feb 2000 | A |
6035101 | Sajoto et al. | Mar 2000 | A |
6037018 | Jang et al. | Mar 2000 | A |
6037266 | Tao et al. | Mar 2000 | A |
6039851 | Iyer | Mar 2000 | A |
6053982 | Halpin et al. | Apr 2000 | A |
6059643 | Hu et al. | May 2000 | A |
6063683 | Wu et al. | May 2000 | A |
6063712 | Gilton et al. | May 2000 | A |
6065424 | Shacham-Diamand et al. | May 2000 | A |
6072147 | Koshiishi | Jun 2000 | A |
6072227 | Yau et al. | Jun 2000 | A |
6074512 | Collins et al. | Jun 2000 | A |
6077780 | Dubin | Jun 2000 | A |
6080529 | Ye et al. | Jun 2000 | A |
6081414 | Flanigan et al. | Jun 2000 | A |
6083344 | Hanawa et al. | Jul 2000 | A |
6083844 | Bui-Le et al. | Jul 2000 | A |
6086677 | Umotoy et al. | Jul 2000 | A |
6087278 | Kim et al. | Jul 2000 | A |
6090212 | Mahawill | Jul 2000 | A |
6093457 | Okumura | Jul 2000 | A |
6093594 | Yeap et al. | Jul 2000 | A |
6099697 | Hausmann | Aug 2000 | A |
6107199 | Allen et al. | Aug 2000 | A |
6110530 | Chen et al. | Aug 2000 | A |
6110832 | Morgan et al. | Aug 2000 | A |
6110836 | Cohen et al. | Aug 2000 | A |
6110838 | Loewenstein | Aug 2000 | A |
6113771 | Landau et al. | Sep 2000 | A |
6117245 | Mandrekar et al. | Sep 2000 | A |
6120640 | Shih et al. | Sep 2000 | A |
6136163 | Cheung et al. | Oct 2000 | A |
6136685 | Narwankar et al. | Oct 2000 | A |
6136693 | Chan et al. | Oct 2000 | A |
6140234 | Uzoh et al. | Oct 2000 | A |
6144099 | Lopatin et al. | Nov 2000 | A |
6147009 | Grill et al. | Nov 2000 | A |
6149828 | Vaartstra | Nov 2000 | A |
6150628 | Smith et al. | Nov 2000 | A |
6153935 | Edelstein et al. | Nov 2000 | A |
6161576 | Maher et al. | Dec 2000 | A |
6162302 | Raghavan et al. | Dec 2000 | A |
6165912 | McConnell et al. | Dec 2000 | A |
6167834 | Wang et al. | Jan 2001 | B1 |
6169021 | Akram et al. | Jan 2001 | B1 |
6170428 | Redeker et al. | Jan 2001 | B1 |
6171661 | Zheng et al. | Jan 2001 | B1 |
6174450 | Patrick et al. | Jan 2001 | B1 |
6174812 | Hsuing et al. | Jan 2001 | B1 |
6176198 | Kao et al. | Jan 2001 | B1 |
6176667 | Fairbairn | Jan 2001 | B1 |
6177245 | Ward et al. | Jan 2001 | B1 |
6179924 | Zhao et al. | Jan 2001 | B1 |
6180523 | Lee et al. | Jan 2001 | B1 |
6182602 | Redeker et al. | Feb 2001 | B1 |
6184121 | Buchwalter et al. | Feb 2001 | B1 |
6186091 | Chu et al. | Feb 2001 | B1 |
6189483 | Ishikawa et al. | Feb 2001 | B1 |
6190233 | Hong et al. | Feb 2001 | B1 |
6194038 | Rossman | Feb 2001 | B1 |
6197181 | Chen | Mar 2001 | B1 |
6197364 | Paunovic et al. | Mar 2001 | B1 |
6197680 | Lin et al. | Mar 2001 | B1 |
6197688 | Simpson | Mar 2001 | B1 |
6197705 | Vassiliev | Mar 2001 | B1 |
6203863 | Liu et al. | Mar 2001 | B1 |
6204200 | Shieh et al. | Mar 2001 | B1 |
6210486 | Mizukami et al. | Apr 2001 | B1 |
6217658 | Orczyk et al. | Apr 2001 | B1 |
6220201 | Nowak | Apr 2001 | B1 |
6228233 | Lakshmikanthan et al. | May 2001 | B1 |
6228751 | Yamazaki et al. | May 2001 | B1 |
6228758 | Pellerin et al. | May 2001 | B1 |
6235643 | Mui et al. | May 2001 | B1 |
6237527 | Kellerman et al. | May 2001 | B1 |
6238513 | Arnold et al. | May 2001 | B1 |
6238582 | Williams et al. | May 2001 | B1 |
6241845 | Gadgil et al. | Jun 2001 | B1 |
6242349 | Nogami et al. | Jun 2001 | B1 |
6244211 | Nishikawa et al. | Jun 2001 | B1 |
6245396 | Nogami | Jun 2001 | B1 |
6245670 | Cheung et al. | Jun 2001 | B1 |
6251236 | Stevens | Jun 2001 | B1 |
6251802 | Moore et al. | Jun 2001 | B1 |
6258170 | Somekh et al. | Jul 2001 | B1 |
6258220 | Dordi et al. | Jul 2001 | B1 |
6258223 | Cheung et al. | Jul 2001 | B1 |
6258270 | Hilgendorff et al. | Jul 2001 | B1 |
6261637 | Oberle | Jul 2001 | B1 |
6277733 | Smith | Aug 2001 | B1 |
6277752 | Chen | Aug 2001 | B1 |
6277763 | Kugimiya et al. | Aug 2001 | B1 |
6281072 | Li et al. | Aug 2001 | B1 |
6281135 | Han et al. | Aug 2001 | B1 |
6284146 | Kim et al. | Sep 2001 | B1 |
6291282 | Wilk et al. | Sep 2001 | B1 |
6291348 | Lopatin et al. | Sep 2001 | B1 |
6303044 | Koemtzopoulos | Oct 2001 | B1 |
6303418 | Cha et al. | Oct 2001 | B1 |
6306772 | Lin | Oct 2001 | B1 |
6308776 | Sloan | Oct 2001 | B1 |
6312554 | Ye | Nov 2001 | B1 |
6312995 | Yu | Nov 2001 | B1 |
6319387 | Krishnamoorthy et al. | Nov 2001 | B1 |
6321587 | Laush | Nov 2001 | B1 |
6322716 | Qiao et al. | Nov 2001 | B1 |
6323128 | Sambucetti et al. | Nov 2001 | B1 |
6335288 | Kwan et al. | Jan 2002 | B1 |
6340435 | Bjorkman et al. | Jan 2002 | B1 |
6342733 | Hu et al. | Jan 2002 | B1 |
RE37546 | Mahawill | Feb 2002 | E |
6344410 | Lopatin et al. | Feb 2002 | B1 |
6348407 | Gupta et al. | Feb 2002 | B1 |
6350320 | Sherstinsky et al. | Feb 2002 | B1 |
6350697 | Richardson | Feb 2002 | B1 |
6351013 | Luning et al. | Feb 2002 | B1 |
6352081 | Lu et al. | Mar 2002 | B1 |
6355573 | Okumura | Mar 2002 | B1 |
6364949 | Or et al. | Apr 2002 | B1 |
6364954 | Umotoy et al. | Apr 2002 | B2 |
6364957 | Schneider et al. | Apr 2002 | B1 |
6375748 | Yudovsky et al. | Apr 2002 | B1 |
6376386 | Oshima | Apr 2002 | B1 |
6379575 | Yin et al. | Apr 2002 | B1 |
6383896 | Kirimura et al. | May 2002 | B1 |
6383951 | Li | May 2002 | B1 |
6387207 | Janakiraman et al. | May 2002 | B1 |
6391753 | Yu | May 2002 | B1 |
6395150 | Van Cleemput et al. | May 2002 | B1 |
6403491 | Liu et al. | Jun 2002 | B1 |
6415736 | Hao et al. | Jul 2002 | B1 |
6416647 | Dordi et al. | Jul 2002 | B1 |
6418874 | Cox et al. | Jul 2002 | B1 |
6423284 | Arno | Jul 2002 | B1 |
6427623 | Ko | Aug 2002 | B2 |
6432819 | Pavate et al. | Aug 2002 | B1 |
6432831 | Dhindsa et al. | Aug 2002 | B2 |
6436193 | Kasai et al. | Aug 2002 | B1 |
6436816 | Lee et al. | Aug 2002 | B1 |
6440863 | Tsai et al. | Aug 2002 | B1 |
6441492 | Cunningham | Aug 2002 | B1 |
6446572 | Brcka | Sep 2002 | B1 |
6448537 | Nering | Sep 2002 | B1 |
6458718 | Todd | Oct 2002 | B1 |
6461974 | Ni et al. | Oct 2002 | B1 |
6462371 | Weimer et al. | Oct 2002 | B1 |
6465051 | Sahin et al. | Oct 2002 | B1 |
6465366 | Nemani et al. | Oct 2002 | B1 |
6477980 | White et al. | Nov 2002 | B1 |
6479373 | Dreybrodt et al. | Nov 2002 | B2 |
6488984 | Wada et al. | Dec 2002 | B1 |
6494959 | Samoilov et al. | Dec 2002 | B1 |
6499425 | Sandhu et al. | Dec 2002 | B1 |
6500728 | Wang | Dec 2002 | B1 |
6503843 | Xia et al. | Jan 2003 | B1 |
6506291 | Tsai et al. | Jan 2003 | B2 |
6509623 | Zhao | Jan 2003 | B2 |
6516815 | Stevens et al. | Feb 2003 | B1 |
6518548 | Sugaya et al. | Feb 2003 | B2 |
6527968 | Wang et al. | Mar 2003 | B1 |
6528409 | Lopatin et al. | Mar 2003 | B1 |
6528751 | Hoffman et al. | Mar 2003 | B1 |
6537707 | Lee | Mar 2003 | B1 |
6537733 | Campana et al. | Mar 2003 | B2 |
6541397 | Bencher | Apr 2003 | B1 |
6541671 | Martinez et al. | Apr 2003 | B1 |
6544340 | Yudovsky | Apr 2003 | B2 |
6547977 | Yan et al. | Apr 2003 | B1 |
6551924 | Dalton et al. | Apr 2003 | B1 |
6558564 | Loewenhardt | May 2003 | B1 |
6565729 | Chen et al. | May 2003 | B2 |
6569773 | Gellrich et al. | May 2003 | B1 |
6572937 | Hakovirta et al. | Jun 2003 | B2 |
6573030 | Fairbairn et al. | Jun 2003 | B1 |
6573606 | Sambucetti et al. | Jun 2003 | B2 |
6585851 | Ohmi et al. | Jul 2003 | B1 |
6586163 | Okabe et al. | Jul 2003 | B1 |
6596599 | Guo | Jul 2003 | B1 |
6596654 | Bayman et al. | Jul 2003 | B1 |
6602434 | Hung et al. | Aug 2003 | B1 |
6603269 | Vo et al. | Aug 2003 | B1 |
6605874 | Leu et al. | Aug 2003 | B2 |
6616967 | Test | Sep 2003 | B1 |
6627532 | Gaillard et al. | Sep 2003 | B1 |
6635578 | Xu et al. | Oct 2003 | B1 |
6638810 | Bakli et al. | Oct 2003 | B2 |
6645301 | Sainty et al. | Nov 2003 | B2 |
6645550 | Cheung et al. | Nov 2003 | B1 |
6656831 | Lee et al. | Dec 2003 | B1 |
6656837 | Xu et al. | Dec 2003 | B2 |
6656848 | Scanlan et al. | Dec 2003 | B1 |
6663715 | Yuda et al. | Dec 2003 | B1 |
6677242 | Liu et al. | Jan 2004 | B1 |
6679981 | Pan et al. | Jan 2004 | B1 |
6688375 | Turner | Feb 2004 | B1 |
6713356 | Skotnicki et al. | Mar 2004 | B1 |
6713835 | Horak et al. | Mar 2004 | B1 |
6717189 | Inoue et al. | Apr 2004 | B2 |
6720213 | Gambino et al. | Apr 2004 | B1 |
6740585 | Yoon et al. | May 2004 | B2 |
6740977 | Ahn et al. | May 2004 | B2 |
6743473 | Parkhe et al. | Jun 2004 | B1 |
6743732 | Lin et al. | Jun 2004 | B1 |
6756235 | Liu et al. | Jun 2004 | B1 |
6759261 | Shimokohbe et al. | Jul 2004 | B2 |
6762127 | Boiteux et al. | Jul 2004 | B2 |
6762435 | Towle | Jul 2004 | B2 |
6764958 | Nemani et al. | Jul 2004 | B1 |
6765273 | Chau et al. | Jul 2004 | B1 |
6767834 | Chung et al. | Jul 2004 | B2 |
6768079 | Kosakai | Jul 2004 | B2 |
6770166 | Fischer | Aug 2004 | B1 |
6772827 | Keller et al. | Aug 2004 | B2 |
6792889 | Nakano et al. | Sep 2004 | B2 |
6794290 | Papasouliotis et al. | Sep 2004 | B1 |
6794311 | Huang et al. | Sep 2004 | B2 |
6796314 | Graff et al. | Sep 2004 | B1 |
6797189 | Hung et al. | Sep 2004 | B2 |
6800336 | Fornsel et al. | Oct 2004 | B1 |
6800830 | Mahawili | Oct 2004 | B2 |
6802944 | Ahmad et al. | Oct 2004 | B2 |
6808564 | Dietze | Oct 2004 | B2 |
6808748 | Kapoor et al. | Oct 2004 | B2 |
6821571 | Huang | Nov 2004 | B2 |
6823589 | White et al. | Nov 2004 | B2 |
6828241 | Kholodenko et al. | Dec 2004 | B2 |
6830624 | Janakiraman et al. | Dec 2004 | B2 |
6835995 | Li | Dec 2004 | B2 |
6846745 | Papasouliotis et al. | Jan 2005 | B1 |
6849854 | Sainty | Feb 2005 | B2 |
6852550 | Tuttle et al. | Feb 2005 | B2 |
6858153 | Bjorkman et al. | Feb 2005 | B2 |
6861097 | Goosey et al. | Mar 2005 | B1 |
6861332 | Park et al. | Mar 2005 | B2 |
6869880 | Krishnaraj et al. | Mar 2005 | B2 |
6875280 | Ikeda et al. | Apr 2005 | B2 |
6878206 | Tzu et al. | Apr 2005 | B2 |
6879981 | Rothschild et al. | Apr 2005 | B2 |
6886491 | Kim et al. | May 2005 | B2 |
6892669 | Xu et al. | May 2005 | B2 |
6893967 | Wright et al. | May 2005 | B1 |
6897532 | Schwarz et al. | May 2005 | B1 |
6900596 | Yang et al. | May 2005 | B2 |
6903511 | Chistyakov | Jun 2005 | B2 |
6908862 | Li et al. | Jun 2005 | B2 |
6911112 | An | Jun 2005 | B2 |
6911401 | Khandan et al. | Jun 2005 | B2 |
6921556 | Shimizu et al. | Jul 2005 | B2 |
6924191 | Liu et al. | Aug 2005 | B2 |
6930047 | Yamazaki | Aug 2005 | B2 |
6935269 | Lee et al. | Aug 2005 | B2 |
6942753 | Choi et al. | Sep 2005 | B2 |
6946033 | Tsuel et al. | Sep 2005 | B2 |
6951821 | Hamelin et al. | Oct 2005 | B2 |
6958175 | Sakamoto et al. | Oct 2005 | B2 |
6958286 | Chen et al. | Oct 2005 | B2 |
6995073 | Liou | Feb 2006 | B2 |
7017269 | White et al. | Mar 2006 | B2 |
7018941 | Cui et al. | Mar 2006 | B2 |
7030034 | Fucsko et al. | Apr 2006 | B2 |
7049200 | Arghavani et al. | May 2006 | B2 |
7052553 | Shih et al. | May 2006 | B1 |
7071532 | Geffken et al. | Jul 2006 | B2 |
7084070 | Lee et al. | Aug 2006 | B1 |
7115525 | Abatchev et al. | Oct 2006 | B2 |
7122949 | Strikovski | Oct 2006 | B2 |
7145725 | Hasel et al. | Dec 2006 | B2 |
7148155 | Tarafdar et al. | Dec 2006 | B1 |
7166233 | Johnson et al. | Jan 2007 | B2 |
7183214 | Nam et al. | Feb 2007 | B2 |
7196342 | Ershov et al. | Mar 2007 | B2 |
7226805 | Hallin et al. | Jun 2007 | B2 |
7235137 | Kitayama et al. | Jun 2007 | B2 |
7244474 | Hanawa et al. | Jul 2007 | B2 |
7252011 | Traverso | Aug 2007 | B2 |
7252716 | Kim et al. | Aug 2007 | B2 |
7253123 | Arghavani et al. | Aug 2007 | B2 |
7256370 | Guiver | Aug 2007 | B2 |
7288482 | Panda et al. | Oct 2007 | B2 |
7291360 | Hanawa et al. | Nov 2007 | B2 |
7316761 | Doan et al. | Jan 2008 | B2 |
7329608 | Babayan et al. | Feb 2008 | B2 |
7341633 | Lubomirsky et al. | Mar 2008 | B2 |
7344912 | Okoronyanwu | Mar 2008 | B1 |
7358192 | Merry et al. | Apr 2008 | B2 |
7361865 | Maki et al. | Apr 2008 | B2 |
7364956 | Saito | Apr 2008 | B2 |
7365016 | Ouellet et al. | Apr 2008 | B2 |
7396480 | Kao et al. | Jul 2008 | B2 |
7416989 | Liu et al. | Aug 2008 | B1 |
7465358 | Weidman et al. | Dec 2008 | B2 |
7465953 | Koh et al. | Dec 2008 | B1 |
7468319 | Lee | Dec 2008 | B2 |
7484473 | Keller et al. | Feb 2009 | B2 |
7488688 | Chung et al. | Feb 2009 | B2 |
7494545 | Lam et al. | Feb 2009 | B2 |
7500445 | Zhao et al. | Mar 2009 | B2 |
7513214 | Okumura et al. | Apr 2009 | B2 |
7520957 | Kao et al. | Apr 2009 | B2 |
7553756 | Hayashi et al. | Jun 2009 | B2 |
7575007 | Tang et al. | Aug 2009 | B2 |
7581511 | Mardian et al. | Sep 2009 | B2 |
7604708 | Wood et al. | Oct 2009 | B2 |
7611980 | Wells | Nov 2009 | B2 |
7628897 | Mungekar et al. | Dec 2009 | B2 |
7682518 | Chandrachood et al. | Mar 2010 | B2 |
7695590 | Hanawa et al. | Apr 2010 | B2 |
7708859 | Huang et al. | May 2010 | B2 |
7722925 | White et al. | May 2010 | B2 |
7723221 | Hayashi | May 2010 | B2 |
7749326 | Kim et al. | Jul 2010 | B2 |
7785672 | Choi et al. | Aug 2010 | B2 |
7790634 | Munro et al. | Sep 2010 | B2 |
7806077 | Lee et al. | Oct 2010 | B2 |
7806078 | Yoshida | Oct 2010 | B2 |
7807578 | Bencher et al. | Oct 2010 | B2 |
7825038 | Ingle et al. | Nov 2010 | B2 |
7837828 | Ikeda et al. | Nov 2010 | B2 |
7845309 | Condrashoff et al. | Dec 2010 | B2 |
7867926 | Satoh et al. | Jan 2011 | B2 |
7915139 | Lang et al. | Mar 2011 | B1 |
7932181 | Singh et al. | Apr 2011 | B2 |
7939422 | Ingle et al. | May 2011 | B2 |
7968441 | Xu | Jun 2011 | B2 |
7976631 | Burrows | Jul 2011 | B2 |
7981806 | Jung | Jul 2011 | B2 |
7989365 | Park et al. | Aug 2011 | B2 |
8008166 | Sanchez et al. | Aug 2011 | B2 |
8048811 | Feustel et al. | Nov 2011 | B2 |
8058179 | Draeger et al. | Nov 2011 | B1 |
8071482 | Kawada | Dec 2011 | B2 |
8074599 | Choi et al. | Dec 2011 | B2 |
8076198 | Lee et al. | Dec 2011 | B2 |
8083853 | Choi et al. | Dec 2011 | B2 |
8114245 | Ohmi et al. | Feb 2012 | B2 |
8119530 | Hori et al. | Feb 2012 | B2 |
8133349 | Panagopoulos | Mar 2012 | B1 |
8183134 | Wu | May 2012 | B2 |
8187486 | Liu et al. | May 2012 | B1 |
8211808 | Sapre et al. | Jul 2012 | B2 |
8272346 | Bettencourt et al. | Sep 2012 | B2 |
8295089 | Jeong et al. | Oct 2012 | B2 |
8298627 | Minami et al. | Oct 2012 | B2 |
8309440 | Sanchez et al. | Nov 2012 | B2 |
8312839 | Baek | Nov 2012 | B2 |
8313610 | Dhindsa | Nov 2012 | B2 |
8328939 | Choi et al. | Dec 2012 | B2 |
8336188 | Monteen | Dec 2012 | B2 |
8357435 | Lubomirsky | Jan 2013 | B2 |
8368308 | Banna et al. | Feb 2013 | B2 |
8390980 | Sansoni et al. | Mar 2013 | B2 |
8427067 | Espiau et al. | Apr 2013 | B2 |
8435902 | Tang et al. | May 2013 | B2 |
8440523 | Guillorn et al. | May 2013 | B1 |
8475674 | Thadani et al. | Jul 2013 | B2 |
8480850 | Tyler et al. | Jul 2013 | B2 |
8491805 | Kushibiki et al. | Jul 2013 | B2 |
8501629 | Tang et al. | Aug 2013 | B2 |
8506713 | Takagi | Aug 2013 | B2 |
8512509 | Bera et al. | Aug 2013 | B2 |
8528889 | Nakano et al. | Sep 2013 | B2 |
8540844 | Hudson et al. | Sep 2013 | B2 |
8551891 | Liang | Oct 2013 | B2 |
8573152 | De La Llera | Nov 2013 | B2 |
8622021 | Taylor et al. | Jan 2014 | B2 |
8623471 | Tyler et al. | Jan 2014 | B2 |
8652298 | Dhindsa et al. | Feb 2014 | B2 |
8679982 | Wang et al. | Mar 2014 | B2 |
8679983 | Wang et al. | Mar 2014 | B2 |
8702902 | Blom et al. | Apr 2014 | B2 |
8741778 | Yang et al. | Jun 2014 | B2 |
8747680 | Deshpande | Jun 2014 | B1 |
8765574 | Zhang et al. | Jul 2014 | B2 |
8771536 | Zhang et al. | Jul 2014 | B2 |
8771539 | Zhang et al. | Jul 2014 | B2 |
8772888 | Jung et al. | Jul 2014 | B2 |
8778079 | Begarney et al. | Jul 2014 | B2 |
8801952 | Wang et al. | Aug 2014 | B1 |
8808563 | Wang et al. | Aug 2014 | B2 |
8846163 | Kao et al. | Sep 2014 | B2 |
8869742 | Dhindsa | Oct 2014 | B2 |
8871651 | Choi et al. | Oct 2014 | B1 |
8888087 | Okabe et al. | Nov 2014 | B2 |
8895449 | Zhu et al. | Nov 2014 | B1 |
8900364 | Wright | Dec 2014 | B2 |
8921234 | Liu et al. | Dec 2014 | B2 |
8927390 | Sapre et al. | Jan 2015 | B2 |
8951429 | Liu et al. | Feb 2015 | B1 |
8956980 | Chen et al. | Feb 2015 | B1 |
8969212 | Ren et al. | Mar 2015 | B2 |
8980005 | Carlson et al. | Mar 2015 | B2 |
8980758 | Ling et al. | Mar 2015 | B1 |
8980763 | Wang et al. | Mar 2015 | B2 |
8992723 | Sorensen et al. | Mar 2015 | B2 |
8999656 | Jirstrom et al. | Apr 2015 | B2 |
8999839 | Su et al. | Apr 2015 | B2 |
8999856 | Zhang et al. | Apr 2015 | B2 |
9012302 | Sapre et al. | Apr 2015 | B2 |
9017481 | Pettinger et al. | Apr 2015 | B1 |
9023732 | Wang et al. | May 2015 | B2 |
9023734 | Chen et al. | May 2015 | B2 |
9034770 | Park et al. | May 2015 | B2 |
9040422 | Wang et al. | May 2015 | B2 |
9064815 | Zhang et al. | Jun 2015 | B2 |
9064816 | Kim et al. | Jun 2015 | B2 |
9072158 | Ikeda et al. | Jun 2015 | B2 |
9093371 | Wang et al. | Jul 2015 | B2 |
9093390 | Wang et al. | Jul 2015 | B2 |
9111877 | Chen et al. | Aug 2015 | B2 |
9111907 | Kamineni | Aug 2015 | B2 |
9114438 | Hoinkis et al. | Aug 2015 | B2 |
9117855 | Cho et al. | Aug 2015 | B2 |
9132436 | Liang et al. | Sep 2015 | B2 |
9136273 | Purayath et al. | Sep 2015 | B1 |
9144147 | Yang et al. | Sep 2015 | B2 |
9153442 | Wang et al. | Oct 2015 | B2 |
9159606 | Purayath et al. | Oct 2015 | B1 |
9165786 | Purayath et al. | Oct 2015 | B1 |
9184055 | Wang et al. | Nov 2015 | B2 |
9190293 | Wang et al. | Nov 2015 | B2 |
9190302 | Ni | Nov 2015 | B2 |
9209012 | Chen et al. | Dec 2015 | B2 |
9236265 | Korolik et al. | Jan 2016 | B2 |
9236266 | Zhang et al. | Jan 2016 | B2 |
9245762 | Zhang et al. | Jan 2016 | B2 |
9263278 | Purayath et al. | Feb 2016 | B2 |
9269590 | Luere et al. | Feb 2016 | B2 |
9275834 | Park et al. | Mar 2016 | B1 |
9287095 | Nguyen et al. | Mar 2016 | B2 |
9287134 | Wang et al. | Mar 2016 | B2 |
9293568 | Ko | Mar 2016 | B2 |
9299537 | Kobayashi et al. | Mar 2016 | B2 |
9299538 | Kobayashi et al. | Mar 2016 | B2 |
9299575 | Park et al. | Mar 2016 | B2 |
9299582 | Ingle et al. | Mar 2016 | B2 |
9299583 | Wang et al. | Mar 2016 | B1 |
9309598 | Wang et al. | Apr 2016 | B2 |
9324576 | Zhang et al. | Apr 2016 | B2 |
9343272 | Pandit et al. | May 2016 | B1 |
9343327 | Zhange et al. | May 2016 | B2 |
9349605 | Xu et al. | May 2016 | B1 |
9355856 | Wang et al. | May 2016 | B2 |
9355862 | Pandit et al. | May 2016 | B2 |
9355863 | Chen et al. | May 2016 | B2 |
9355922 | Park et al. | May 2016 | B2 |
9362130 | Ingle et al. | Jun 2016 | B2 |
9368364 | Park et al. | Jun 2016 | B2 |
9373517 | Yang et al. | Jun 2016 | B2 |
9373522 | Wang et al. | Jun 2016 | B1 |
9378969 | Hsu et al. | Jun 2016 | B2 |
9378978 | Purayath et al. | Jun 2016 | B2 |
9384997 | Ren et al. | Jul 2016 | B2 |
9385028 | Nemani et al. | Jul 2016 | B2 |
9390937 | Chen et al. | Jul 2016 | B2 |
9396989 | Purayath et al. | Jul 2016 | B2 |
9406523 | Chen et al. | Aug 2016 | B2 |
9412608 | Wang et al. | Aug 2016 | B2 |
9418858 | Wang et al. | Aug 2016 | B2 |
9425058 | Kim et al. | Aug 2016 | B2 |
9437451 | Chen et al. | Sep 2016 | B2 |
9449845 | Liu et al. | Sep 2016 | B2 |
9449846 | Liu et al. | Sep 2016 | B2 |
9449850 | Wang et al. | Sep 2016 | B2 |
9472412 | Zhang et al. | Oct 2016 | B2 |
9472417 | Ingle et al. | Oct 2016 | B2 |
9478432 | Chen et al. | Oct 2016 | B2 |
9478434 | Wang et al. | Oct 2016 | B2 |
9493879 | Hoinkis et al. | Nov 2016 | B2 |
9496167 | Purayath et al. | Nov 2016 | B2 |
9499898 | Nguyen et al. | Nov 2016 | B2 |
9502258 | Xue et al. | Nov 2016 | B2 |
9520303 | Wang et al. | Dec 2016 | B2 |
9564296 | Kobayashi et al. | Feb 2017 | B2 |
9576809 | Korolik et al. | Feb 2017 | B2 |
9607856 | Wang et al. | Mar 2017 | B2 |
9613822 | Chen et al. | Apr 2017 | B2 |
20010006093 | Tabuchi | Jul 2001 | A1 |
20010008803 | Takamatsu et al. | Jul 2001 | A1 |
20010015261 | Kobayashi et al. | Aug 2001 | A1 |
20010028093 | Yamazaki et al. | Oct 2001 | A1 |
20010028922 | Sandhu | Oct 2001 | A1 |
20010030366 | Nakano et al. | Oct 2001 | A1 |
20010034106 | Moise et al. | Oct 2001 | A1 |
20010034121 | Fu et al. | Oct 2001 | A1 |
20010035124 | Okayama et al. | Nov 2001 | A1 |
20010036706 | Kitamura | Nov 2001 | A1 |
20010037856 | Park | Nov 2001 | A1 |
20010037941 | Thompson | Nov 2001 | A1 |
20010039921 | Rolfson et al. | Nov 2001 | A1 |
20010042512 | Xu et al. | Nov 2001 | A1 |
20010053585 | Kikuchi et al. | Dec 2001 | A1 |
20010053610 | Athavale | Dec 2001 | A1 |
20020000202 | Yuda et al. | Jan 2002 | A1 |
20020001778 | Latchford et al. | Jan 2002 | A1 |
20020011210 | Satoh et al. | Jan 2002 | A1 |
20020011214 | Kamarehi et al. | Jan 2002 | A1 |
20020016080 | Khan et al. | Feb 2002 | A1 |
20020016085 | Huang et al. | Feb 2002 | A1 |
20020023899 | Khater et al. | Feb 2002 | A1 |
20020028582 | Nallan et al. | Mar 2002 | A1 |
20020028585 | Chung et al. | Mar 2002 | A1 |
20020029747 | Powell et al. | Mar 2002 | A1 |
20020033233 | Savas | Mar 2002 | A1 |
20020036143 | Segawa et al. | Mar 2002 | A1 |
20020040764 | Kwan et al. | Apr 2002 | A1 |
20020040766 | Takahashi | Apr 2002 | A1 |
20020043690 | Doyle et al. | Apr 2002 | A1 |
20020045966 | Lee et al. | Apr 2002 | A1 |
20020054962 | Huang | May 2002 | A1 |
20020069820 | Yudovsky | Jun 2002 | A1 |
20020070414 | Drescher et al. | Jun 2002 | A1 |
20020074573 | Takeuchi et al. | Jun 2002 | A1 |
20020090781 | Skotnicki et al. | Jul 2002 | A1 |
20020090835 | Chakravarti et al. | Jul 2002 | A1 |
20020094378 | O'Donnell | Jul 2002 | A1 |
20020094591 | Sill et al. | Jul 2002 | A1 |
20020096493 | Hattori | Jul 2002 | A1 |
20020098681 | Hu et al. | Jul 2002 | A1 |
20020106845 | Chao et al. | Aug 2002 | A1 |
20020112819 | Kamarehi et al. | Aug 2002 | A1 |
20020124867 | Kim et al. | Sep 2002 | A1 |
20020129769 | Kim et al. | Sep 2002 | A1 |
20020129902 | Babayan et al. | Sep 2002 | A1 |
20020144657 | Chiang et al. | Oct 2002 | A1 |
20020153808 | Skotnicki et al. | Oct 2002 | A1 |
20020164885 | Lill et al. | Nov 2002 | A1 |
20020177322 | Li et al. | Nov 2002 | A1 |
20020182878 | Hirose et al. | Dec 2002 | A1 |
20020187280 | Johnson et al. | Dec 2002 | A1 |
20020187655 | Tan et al. | Dec 2002 | A1 |
20030003757 | Naltan et al. | Jan 2003 | A1 |
20030007910 | Lazarovich et al. | Jan 2003 | A1 |
20030010645 | Ting et al. | Jan 2003 | A1 |
20030019428 | Ku et al. | Jan 2003 | A1 |
20030019580 | Strang | Jan 2003 | A1 |
20030026060 | Hiramatsu et al. | Feb 2003 | A1 |
20030029566 | Roth | Feb 2003 | A1 |
20030029567 | Dhindsa et al. | Feb 2003 | A1 |
20030029715 | Yu et al. | Feb 2003 | A1 |
20030032284 | Enomoto et al. | Feb 2003 | A1 |
20030038127 | Liu et al. | Feb 2003 | A1 |
20030038305 | Wasshuber | Feb 2003 | A1 |
20030054608 | Tseng et al. | Mar 2003 | A1 |
20030071035 | Brailove | Apr 2003 | A1 |
20030072639 | White et al. | Apr 2003 | A1 |
20030075808 | Inoue et al. | Apr 2003 | A1 |
20030077909 | Jiwari | Apr 2003 | A1 |
20030079686 | Chen et al. | May 2003 | A1 |
20030087531 | Kang et al. | May 2003 | A1 |
20030091938 | Fairbairn et al. | May 2003 | A1 |
20030094134 | Minami et al. | May 2003 | A1 |
20030098125 | An | May 2003 | A1 |
20030109143 | Hsieh et al. | Jun 2003 | A1 |
20030116087 | Nguyen et al. | Jun 2003 | A1 |
20030116439 | Seo et al. | Jun 2003 | A1 |
20030121608 | Chen et al. | Jul 2003 | A1 |
20030121609 | Ohmi et al. | Jul 2003 | A1 |
20030124465 | Lee et al. | Jul 2003 | A1 |
20030124842 | Hytros et al. | Jul 2003 | A1 |
20030127740 | Hsu et al. | Jul 2003 | A1 |
20030129106 | Sorensen et al. | Jul 2003 | A1 |
20030129827 | Lee et al. | Jul 2003 | A1 |
20030132319 | Hytros et al. | Jul 2003 | A1 |
20030140844 | Maa et al. | Jul 2003 | A1 |
20030143328 | Chen et al. | Jul 2003 | A1 |
20030148035 | Lingampalli | Aug 2003 | A1 |
20030152691 | Baude | Aug 2003 | A1 |
20030159307 | Sago et al. | Aug 2003 | A1 |
20030168439 | Kanno et al. | Sep 2003 | A1 |
20030170945 | Igeta et al. | Sep 2003 | A1 |
20030173333 | Wang et al. | Sep 2003 | A1 |
20030173347 | Guiver | Sep 2003 | A1 |
20030173675 | Watanabe | Sep 2003 | A1 |
20030181040 | Ivanov et al. | Sep 2003 | A1 |
20030183244 | Rossman | Oct 2003 | A1 |
20030190426 | Padhi et al. | Oct 2003 | A1 |
20030199170 | Li | Oct 2003 | A1 |
20030200929 | Otsuki | Oct 2003 | A1 |
20030205329 | Gujer et al. | Nov 2003 | A1 |
20030215963 | AmRhein et al. | Nov 2003 | A1 |
20030216044 | Lin et al. | Nov 2003 | A1 |
20030221780 | Lei et al. | Dec 2003 | A1 |
20030224217 | Byun et al. | Dec 2003 | A1 |
20030224617 | Baek et al. | Dec 2003 | A1 |
20040005726 | Huang | Jan 2004 | A1 |
20040018304 | Chung et al. | Jan 2004 | A1 |
20040020801 | Solling | Feb 2004 | A1 |
20040026371 | Nguyen et al. | Feb 2004 | A1 |
20040033678 | Arghavani et al. | Feb 2004 | A1 |
20040033684 | Li | Feb 2004 | A1 |
20040050328 | Kumagai et al. | Mar 2004 | A1 |
20040058293 | Nguyen et al. | Mar 2004 | A1 |
20040069225 | Fairbairn et al. | Apr 2004 | A1 |
20040070346 | Choi | Apr 2004 | A1 |
20040072446 | Liu et al. | Apr 2004 | A1 |
20040076529 | Gnauck et al. | Apr 2004 | A1 |
20040083967 | Yuda et al. | May 2004 | A1 |
20040087139 | Yeh et al. | May 2004 | A1 |
20040092063 | Okumura | May 2004 | A1 |
20040099378 | Kim et al. | May 2004 | A1 |
20040101667 | O'Loughlin et al. | May 2004 | A1 |
20040107908 | Collins et al. | Jun 2004 | A1 |
20040108067 | Fischione et al. | Jun 2004 | A1 |
20040108068 | Senzaki et al. | Jun 2004 | A1 |
20040115876 | Goundar et al. | Jun 2004 | A1 |
20040129671 | Ji et al. | Jul 2004 | A1 |
20040137161 | Segawa et al. | Jul 2004 | A1 |
20040144490 | Zhao et al. | Jul 2004 | A1 |
20040147126 | Yamashita et al. | Jul 2004 | A1 |
20040149394 | Doan et al. | Aug 2004 | A1 |
20040152342 | Li | Aug 2004 | A1 |
20040154535 | Chen et al. | Aug 2004 | A1 |
20040157444 | Chiu | Aug 2004 | A1 |
20040161921 | Ryu | Aug 2004 | A1 |
20040175913 | Johnson et al. | Sep 2004 | A1 |
20040175929 | Schmitt et al. | Sep 2004 | A1 |
20040182315 | Laflamme et al. | Sep 2004 | A1 |
20040192032 | Ohmori et al. | Sep 2004 | A1 |
20040194799 | Kim et al. | Oct 2004 | A1 |
20040200499 | Harvey | Oct 2004 | A1 |
20040211357 | Gadgil et al. | Oct 2004 | A1 |
20040219737 | Quon | Nov 2004 | A1 |
20040219789 | Wood et al. | Nov 2004 | A1 |
20040231706 | Bhatnagar et al. | Nov 2004 | A1 |
20040263827 | Xu | Dec 2004 | A1 |
20050001276 | Gao et al. | Jan 2005 | A1 |
20050003676 | Ho et al. | Jan 2005 | A1 |
20050009340 | Saijo et al. | Jan 2005 | A1 |
20050009358 | Choi et al. | Jan 2005 | A1 |
20050026430 | Kim et al. | Feb 2005 | A1 |
20050026431 | Kazumi et al. | Feb 2005 | A1 |
20050035455 | Hu et al. | Feb 2005 | A1 |
20050051094 | Schaepkens et al. | Mar 2005 | A1 |
20050073051 | Yamamoto et al. | Apr 2005 | A1 |
20050079706 | Kumar et al. | Apr 2005 | A1 |
20050090078 | Ishihara | Apr 2005 | A1 |
20050090120 | Hasegawa et al. | Apr 2005 | A1 |
20050098111 | Shimizu et al. | May 2005 | A1 |
20050105991 | Hofmeister et al. | May 2005 | A1 |
20050112876 | Wu | May 2005 | A1 |
20050112901 | Ji et al. | May 2005 | A1 |
20050164479 | Perng et al. | Jul 2005 | A1 |
20050167394 | Liu et al. | Aug 2005 | A1 |
20050176258 | Hirose et al. | Aug 2005 | A1 |
20050181588 | Kim | Aug 2005 | A1 |
20050183666 | Tsuji et al. | Aug 2005 | A1 |
20050196967 | Savas et al. | Sep 2005 | A1 |
20050199489 | Stevens et al. | Sep 2005 | A1 |
20050205110 | Kao et al. | Sep 2005 | A1 |
20050205862 | Koemtzopoulos et al. | Sep 2005 | A1 |
20050208215 | Eguchi et al. | Sep 2005 | A1 |
20050214477 | Hanawa et al. | Sep 2005 | A1 |
20050218507 | Kao et al. | Oct 2005 | A1 |
20050219786 | Brown et al. | Oct 2005 | A1 |
20050221552 | Kao et al. | Oct 2005 | A1 |
20050230350 | Kao et al. | Oct 2005 | A1 |
20050236694 | Wu et al. | Oct 2005 | A1 |
20050239282 | Chen et al. | Oct 2005 | A1 |
20050251990 | Choi et al. | Nov 2005 | A1 |
20050266622 | Arghavani et al. | Dec 2005 | A1 |
20050266650 | Ahn et al. | Dec 2005 | A1 |
20050266691 | Gu et al. | Dec 2005 | A1 |
20050269030 | Kent et al. | Dec 2005 | A1 |
20050274324 | Takahashi et al. | Dec 2005 | A1 |
20050279454 | Snijders | Dec 2005 | A1 |
20050287755 | Bachmann | Dec 2005 | A1 |
20050287771 | Seamons et al. | Dec 2005 | A1 |
20060000802 | Kumar et al. | Jan 2006 | A1 |
20060000805 | Todorow et al. | Jan 2006 | A1 |
20060005856 | Sun et al. | Jan 2006 | A1 |
20060005930 | Ikeda et al. | Jan 2006 | A1 |
20060006057 | Laermer | Jan 2006 | A1 |
20060011298 | Lim et al. | Jan 2006 | A1 |
20060011299 | Condrashoff et al. | Jan 2006 | A1 |
20060016783 | Wu et al. | Jan 2006 | A1 |
20060019456 | Bu et al. | Jan 2006 | A1 |
20060019486 | Yu et al. | Jan 2006 | A1 |
20060021574 | Armour et al. | Feb 2006 | A1 |
20060024954 | Wu et al. | Feb 2006 | A1 |
20060024956 | Zhijian et al. | Feb 2006 | A1 |
20060033678 | Lubomirsky et al. | Feb 2006 | A1 |
20060040055 | Nguyen et al. | Feb 2006 | A1 |
20060043066 | Kamp | Mar 2006 | A1 |
20060046412 | Nguyen et al. | Mar 2006 | A1 |
20060046419 | Sandhu et al. | Mar 2006 | A1 |
20060046470 | Becknell | Mar 2006 | A1 |
20060051966 | Or et al. | Mar 2006 | A1 |
20060051968 | Joshi et al. | Mar 2006 | A1 |
20060054184 | Mozetic et al. | Mar 2006 | A1 |
20060060942 | Minixhofer et al. | Mar 2006 | A1 |
20060087644 | McMillin et al. | Apr 2006 | A1 |
20060093756 | Rajagopalan et al. | May 2006 | A1 |
20060097397 | Russell et al. | May 2006 | A1 |
20060102076 | Smith et al. | May 2006 | A1 |
20060102587 | Kimura | May 2006 | A1 |
20060118178 | Desbiolles et al. | Jun 2006 | A1 |
20060121724 | Yue et al. | Jun 2006 | A1 |
20060124242 | Kanarik et al. | Jun 2006 | A1 |
20060130971 | Chang et al. | Jun 2006 | A1 |
20060157449 | Takahashi et al. | Jul 2006 | A1 |
20060162661 | Jung et al. | Jul 2006 | A1 |
20060166107 | Chen et al. | Jul 2006 | A1 |
20060166515 | Karim et al. | Jul 2006 | A1 |
20060169327 | Shajii et al. | Aug 2006 | A1 |
20060178008 | Yeh et al. | Aug 2006 | A1 |
20060185592 | Matsuura | Aug 2006 | A1 |
20060191479 | Mizukami et al. | Aug 2006 | A1 |
20060191637 | Zajac et al. | Aug 2006 | A1 |
20060207504 | Hasebe et al. | Sep 2006 | A1 |
20060207595 | Ohmi et al. | Sep 2006 | A1 |
20060210723 | Ishizaka | Sep 2006 | A1 |
20060216878 | Lee | Sep 2006 | A1 |
20060219360 | Iwasaki | Oct 2006 | A1 |
20060222481 | Foree | Oct 2006 | A1 |
20060226121 | Aoi | Oct 2006 | A1 |
20060228889 | Edelberg et al. | Oct 2006 | A1 |
20060240661 | Annapragada et al. | Oct 2006 | A1 |
20060244107 | Sugihara | Nov 2006 | A1 |
20060246217 | Weidman et al. | Nov 2006 | A1 |
20060251800 | Weidman et al. | Nov 2006 | A1 |
20060251801 | Weidman et al. | Nov 2006 | A1 |
20060252252 | Zhu et al. | Nov 2006 | A1 |
20060252265 | Jin et al. | Nov 2006 | A1 |
20060254716 | Mosden et al. | Nov 2006 | A1 |
20060260750 | Rueger | Nov 2006 | A1 |
20060261490 | Su et al. | Nov 2006 | A1 |
20060264043 | Stewart et al. | Nov 2006 | A1 |
20060266288 | Choi | Nov 2006 | A1 |
20060292846 | Pinto et al. | Dec 2006 | A1 |
20070025907 | Rezeq | Feb 2007 | A1 |
20070048977 | Lee et al. | Mar 2007 | A1 |
20070056925 | Liu et al. | Mar 2007 | A1 |
20070062453 | Ishikawa | Mar 2007 | A1 |
20070071888 | Shanmugasundram et al. | Mar 2007 | A1 |
20070072408 | Enomoto et al. | Mar 2007 | A1 |
20070090325 | Hwang et al. | Apr 2007 | A1 |
20070099428 | Shamiryan et al. | May 2007 | A1 |
20070099431 | Li | May 2007 | A1 |
20070099438 | Ye et al. | May 2007 | A1 |
20070107750 | Sawin et al. | May 2007 | A1 |
20070108404 | Stewart et al. | May 2007 | A1 |
20070111519 | Lubomirsky et al. | May 2007 | A1 |
20070117396 | Wu et al. | May 2007 | A1 |
20070119370 | Ma et al. | May 2007 | A1 |
20070119371 | Ma et al. | May 2007 | A1 |
20070123051 | Arghavani et al. | May 2007 | A1 |
20070131274 | Stollwerck et al. | Jun 2007 | A1 |
20070145023 | Holber et al. | Jun 2007 | A1 |
20070154838 | Lee | Jul 2007 | A1 |
20070163440 | Kim et al. | Jul 2007 | A1 |
20070175861 | Hwang et al. | Aug 2007 | A1 |
20070181057 | Lam et al. | Aug 2007 | A1 |
20070193515 | Jeon et al. | Aug 2007 | A1 |
20070197028 | Byun et al. | Aug 2007 | A1 |
20070207275 | Nowak et al. | Sep 2007 | A1 |
20070212288 | Holst | Sep 2007 | A1 |
20070227554 | Satoh et al. | Oct 2007 | A1 |
20070231109 | Pak et al. | Oct 2007 | A1 |
20070235134 | Iimuro | Oct 2007 | A1 |
20070238199 | Yamashita | Oct 2007 | A1 |
20070238321 | Futase et al. | Oct 2007 | A1 |
20070243685 | Jiang et al. | Oct 2007 | A1 |
20070243714 | Shin et al. | Oct 2007 | A1 |
20070254169 | Kamins et al. | Nov 2007 | A1 |
20070259467 | Tweet et al. | Nov 2007 | A1 |
20070264820 | Liu | Nov 2007 | A1 |
20070266946 | Choi | Nov 2007 | A1 |
20070277734 | Lubomirsky et al. | Dec 2007 | A1 |
20070281106 | Lubomirsky et al. | Dec 2007 | A1 |
20070287292 | Li et al. | Dec 2007 | A1 |
20070296967 | Gupta et al. | Dec 2007 | A1 |
20080017104 | Matyushkin et al. | Jan 2008 | A1 |
20080020570 | Naik | Jan 2008 | A1 |
20080044990 | Lee | Feb 2008 | A1 |
20080063810 | Park et al. | Mar 2008 | A1 |
20080075668 | Goldstein | Mar 2008 | A1 |
20080081483 | Wu | Apr 2008 | A1 |
20080085604 | Hoshino et al. | Apr 2008 | A1 |
20080099147 | Myo et al. | May 2008 | A1 |
20080099431 | Kumar et al. | May 2008 | A1 |
20080099876 | Seto | May 2008 | A1 |
20080102570 | Fischer et al. | May 2008 | A1 |
20080102640 | Hassan et al. | May 2008 | A1 |
20080104782 | Hughes | May 2008 | A1 |
20080115726 | Ingle et al. | May 2008 | A1 |
20080121970 | Aritome | May 2008 | A1 |
20080124937 | Xu et al. | May 2008 | A1 |
20080142831 | Su | Jun 2008 | A1 |
20080153306 | Cho et al. | Jun 2008 | A1 |
20080156771 | Jeon et al. | Jul 2008 | A1 |
20080157225 | Datta et al. | Jul 2008 | A1 |
20080160210 | Yang et al. | Jul 2008 | A1 |
20080171407 | Nakabayashi et al. | Jul 2008 | A1 |
20080173906 | Zhu | Jul 2008 | A1 |
20080176412 | Komeda | Jul 2008 | A1 |
20080182381 | Kiyotoshi | Jul 2008 | A1 |
20080182383 | Lee et al. | Jul 2008 | A1 |
20080202892 | Smith et al. | Aug 2008 | A1 |
20080230519 | Takahashi | Sep 2008 | A1 |
20080233709 | Conti et al. | Sep 2008 | A1 |
20080236751 | Aramaki et al. | Oct 2008 | A1 |
20080254635 | Benzel et al. | Oct 2008 | A1 |
20080261404 | Kozuka et al. | Oct 2008 | A1 |
20080264337 | Sano et al. | Oct 2008 | A1 |
20080268645 | Kao et al. | Oct 2008 | A1 |
20080292798 | Huh et al. | Nov 2008 | A1 |
20080293248 | Park et al. | Nov 2008 | A1 |
20090001480 | Cheng | Jan 2009 | A1 |
20090004849 | Eun | Jan 2009 | A1 |
20090014127 | Shah et al. | Jan 2009 | A1 |
20090014323 | Yendler et al. | Jan 2009 | A1 |
20090017227 | Fu et al. | Jan 2009 | A1 |
20090045167 | Maruyama | Feb 2009 | A1 |
20090072401 | Arnold et al. | Mar 2009 | A1 |
20090081878 | Dhindsa | Mar 2009 | A1 |
20090084317 | Wu et al. | Apr 2009 | A1 |
20090087960 | Cho et al. | Apr 2009 | A1 |
20090087979 | Raghuram | Apr 2009 | A1 |
20090095621 | Kao et al. | Apr 2009 | A1 |
20090098706 | Kim et al. | Apr 2009 | A1 |
20090104738 | Ring et al. | Apr 2009 | A1 |
20090104782 | Lu et al. | Apr 2009 | A1 |
20090111280 | Kao et al. | Apr 2009 | A1 |
20090120464 | Rasheed et al. | May 2009 | A1 |
20090170221 | Jacques et al. | Jul 2009 | A1 |
20090170331 | Cheng et al. | Jul 2009 | A1 |
20090179300 | Arai | Jul 2009 | A1 |
20090189246 | Wu et al. | Jul 2009 | A1 |
20090194810 | Kiyotoshi et al. | Aug 2009 | A1 |
20090197418 | Sago | Aug 2009 | A1 |
20090202721 | Nogami et al. | Aug 2009 | A1 |
20090255902 | Satoh et al. | Oct 2009 | A1 |
20090258162 | Furuta et al. | Oct 2009 | A1 |
20090269934 | Kao et al. | Oct 2009 | A1 |
20090274590 | Willwerth et al. | Nov 2009 | A1 |
20090275146 | Takano et al. | Nov 2009 | A1 |
20090275205 | Kiehlbauch et al. | Nov 2009 | A1 |
20090275206 | Katz et al. | Nov 2009 | A1 |
20090277587 | Lubomirsky et al. | Nov 2009 | A1 |
20090277874 | Rui et al. | Nov 2009 | A1 |
20090280650 | Lubomirsky et al. | Nov 2009 | A1 |
20090286400 | Heo et al. | Nov 2009 | A1 |
20090294898 | Feustel et al. | Dec 2009 | A1 |
20090317978 | Higashi | Dec 2009 | A1 |
20090320756 | Tanaka | Dec 2009 | A1 |
20100003824 | Kadkhodayan et al. | Jan 2010 | A1 |
20100022030 | Ditizio | Jan 2010 | A1 |
20100047080 | Bruce | Feb 2010 | A1 |
20100048027 | Cheng et al. | Feb 2010 | A1 |
20100055408 | Lee et al. | Mar 2010 | A1 |
20100055917 | Kim | Mar 2010 | A1 |
20100059889 | Gosset et al. | Mar 2010 | A1 |
20100062603 | Ganguly et al. | Mar 2010 | A1 |
20100075503 | Bencher | Mar 2010 | A1 |
20100081285 | Chen et al. | Apr 2010 | A1 |
20100093151 | Arghavani et al. | Apr 2010 | A1 |
20100093168 | Naik | Apr 2010 | A1 |
20100096367 | Jeon et al. | Apr 2010 | A1 |
20100099236 | Kwon et al. | Apr 2010 | A1 |
20100099263 | Kao et al. | Apr 2010 | A1 |
20100101727 | Ji | Apr 2010 | A1 |
20100105209 | Winniczek et al. | Apr 2010 | A1 |
20100116788 | Singh et al. | May 2010 | A1 |
20100130001 | Noguchi | May 2010 | A1 |
20100144140 | Chandrashekar et al. | Jun 2010 | A1 |
20100147219 | Hsieh et al. | Jun 2010 | A1 |
20100164422 | Shu et al. | Jul 2010 | A1 |
20100173499 | Tao et al. | Jul 2010 | A1 |
20100178748 | Subramanian | Jul 2010 | A1 |
20100178755 | Lee et al. | Jul 2010 | A1 |
20100180819 | Hatanaka et al. | Jul 2010 | A1 |
20100183825 | Becker et al. | Jul 2010 | A1 |
20100187534 | Nishi et al. | Jul 2010 | A1 |
20100187588 | Kim et al. | Jul 2010 | A1 |
20100187694 | Yu et al. | Jul 2010 | A1 |
20100190352 | Jaiswal | Jul 2010 | A1 |
20100197143 | Nishimura | Aug 2010 | A1 |
20100203739 | Becker et al. | Aug 2010 | A1 |
20100207205 | Grebs et al. | Aug 2010 | A1 |
20100240205 | Son | Sep 2010 | A1 |
20100258913 | Lue | Oct 2010 | A1 |
20100288369 | Chang et al. | Nov 2010 | A1 |
20100294199 | Tran et al. | Nov 2010 | A1 |
20100330814 | Yokota et al. | Dec 2010 | A1 |
20110005607 | Desbiolles et al. | Jan 2011 | A1 |
20110008950 | Xu | Jan 2011 | A1 |
20110011338 | Chuc et al. | Jan 2011 | A1 |
20110034035 | Liang et al. | Feb 2011 | A1 |
20110039407 | Nishizuka | Feb 2011 | A1 |
20110045676 | Park | Feb 2011 | A1 |
20110053380 | Sapre et al. | Mar 2011 | A1 |
20110058303 | Migita | Mar 2011 | A1 |
20110061810 | Ganguly et al. | Mar 2011 | A1 |
20110061812 | Ganguly et al. | Mar 2011 | A1 |
20110065276 | Ganguly et al. | Mar 2011 | A1 |
20110081782 | Liang et al. | Apr 2011 | A1 |
20110100489 | Orito | May 2011 | A1 |
20110111596 | Kanakasabapathy | May 2011 | A1 |
20110114601 | Lubomirsky et al. | May 2011 | A1 |
20110115378 | Lubomirsky et al. | May 2011 | A1 |
20110124144 | Schlemm et al. | May 2011 | A1 |
20110127156 | Foad et al. | Jun 2011 | A1 |
20110140229 | Rachmady et al. | Jun 2011 | A1 |
20110143542 | Feurprier et al. | Jun 2011 | A1 |
20110151674 | Tang et al. | Jun 2011 | A1 |
20110151677 | Wang et al. | Jun 2011 | A1 |
20110151678 | Ashtiani et al. | Jun 2011 | A1 |
20110155181 | Inatomi | Jun 2011 | A1 |
20110159690 | Chandrashekar et al. | Jun 2011 | A1 |
20110165057 | Honda et al. | Jul 2011 | A1 |
20110165771 | Ring et al. | Jul 2011 | A1 |
20110174778 | Sawada et al. | Jul 2011 | A1 |
20110180847 | Ikeda et al. | Jul 2011 | A1 |
20110195575 | Wang | Aug 2011 | A1 |
20110217851 | Liang et al. | Sep 2011 | A1 |
20110226734 | Sumiya et al. | Sep 2011 | A1 |
20110227028 | Sekar et al. | Sep 2011 | A1 |
20110230008 | Lakshmanan et al. | Sep 2011 | A1 |
20110230052 | Tang et al. | Sep 2011 | A1 |
20110232737 | Ruletzki et al. | Sep 2011 | A1 |
20110266252 | Thadani et al. | Nov 2011 | A1 |
20110266682 | Edelstein et al. | Nov 2011 | A1 |
20110287633 | Lee et al. | Nov 2011 | A1 |
20110294300 | Zhang et al. | Dec 2011 | A1 |
20110298061 | Siddiqui et al. | Dec 2011 | A1 |
20120003782 | Byun et al. | Jan 2012 | A1 |
20120009796 | Cui et al. | Jan 2012 | A1 |
20120025289 | Liang et al. | Feb 2012 | A1 |
20120031559 | Dhindsa et al. | Feb 2012 | A1 |
20120034786 | Dhindsa et al. | Feb 2012 | A1 |
20120035766 | Shajii et al. | Feb 2012 | A1 |
20120052683 | Kim et al. | Mar 2012 | A1 |
20120068242 | Shin et al. | Mar 2012 | A1 |
20120091108 | Lin et al. | Apr 2012 | A1 |
20120103518 | Kakimoto | May 2012 | A1 |
20120104564 | Won et al. | May 2012 | A1 |
20120129354 | Luong | May 2012 | A1 |
20120135576 | Lee et al. | May 2012 | A1 |
20120148369 | Michalski et al. | Jun 2012 | A1 |
20120149200 | Culp et al. | Jun 2012 | A1 |
20120161405 | Mohn et al. | Jun 2012 | A1 |
20120164839 | Nishimura | Jun 2012 | A1 |
20120180954 | Yang et al. | Jul 2012 | A1 |
20120181599 | Lung | Jul 2012 | A1 |
20120182808 | Lue et al. | Jul 2012 | A1 |
20120196447 | Yang et al. | Aug 2012 | A1 |
20120202408 | Shajii et al. | Aug 2012 | A1 |
20120208361 | Ha | Aug 2012 | A1 |
20120211462 | Zhang et al. | Aug 2012 | A1 |
20120223048 | Paranjpe et al. | Sep 2012 | A1 |
20120223418 | Stowers et al. | Sep 2012 | A1 |
20120225557 | Serry et al. | Sep 2012 | A1 |
20120228642 | Aube et al. | Sep 2012 | A1 |
20120238102 | Zhang et al. | Sep 2012 | A1 |
20120238103 | Zhang et al. | Sep 2012 | A1 |
20120241411 | Darling et al. | Sep 2012 | A1 |
20120247390 | Sawada et al. | Oct 2012 | A1 |
20120247670 | Dobashi et al. | Oct 2012 | A1 |
20120247671 | Sugawara | Oct 2012 | A1 |
20120258600 | Godet et al. | Oct 2012 | A1 |
20120267346 | Kao et al. | Oct 2012 | A1 |
20120282779 | Arnold et al. | Nov 2012 | A1 |
20120285619 | Matyushkin et al. | Nov 2012 | A1 |
20120285621 | Tan | Nov 2012 | A1 |
20120292664 | Kanike | Nov 2012 | A1 |
20120309204 | Kang et al. | Dec 2012 | A1 |
20130001899 | Hwang et al. | Jan 2013 | A1 |
20130005103 | Liu et al. | Jan 2013 | A1 |
20130005140 | Jeng et al. | Jan 2013 | A1 |
20130012032 | Liu et al. | Jan 2013 | A1 |
20130032574 | Liu et al. | Feb 2013 | A1 |
20130034666 | Liang et al. | Feb 2013 | A1 |
20130034968 | Zhang et al. | Feb 2013 | A1 |
20130045605 | Wang et al. | Feb 2013 | A1 |
20130052827 | Wang et al. | Feb 2013 | A1 |
20130052833 | Ranjan et al. | Feb 2013 | A1 |
20130059440 | Wang et al. | Mar 2013 | A1 |
20130062675 | Thomas | Mar 2013 | A1 |
20130065398 | Ohsawa et al. | Mar 2013 | A1 |
20130082197 | Yang et al. | Apr 2013 | A1 |
20130084654 | Gaylord et al. | Apr 2013 | A1 |
20130089988 | Wang et al. | Apr 2013 | A1 |
20130098868 | Nishimura et al. | Apr 2013 | A1 |
20130105948 | Kewley | May 2013 | A1 |
20130119016 | Kagoshima | May 2013 | A1 |
20130119457 | Lue et al. | May 2013 | A1 |
20130119483 | Alptekin et al. | May 2013 | A1 |
20130130507 | Wang et al. | May 2013 | A1 |
20130150303 | Kungl et al. | Jun 2013 | A1 |
20130161726 | Kim et al. | Jun 2013 | A1 |
20130171810 | Sun et al. | Jul 2013 | A1 |
20130175654 | Muckenhirn et al. | Jul 2013 | A1 |
20130187220 | Surthi | Jul 2013 | A1 |
20130193108 | Zheng | Aug 2013 | A1 |
20130217243 | Underwood et al. | Aug 2013 | A1 |
20130224960 | Payyapilly et al. | Aug 2013 | A1 |
20130260533 | Sapre et al. | Oct 2013 | A1 |
20130260564 | Sapre et al. | Oct 2013 | A1 |
20130279066 | Lubomirsky et al. | Oct 2013 | A1 |
20130284369 | Kobayashi et al. | Oct 2013 | A1 |
20130284370 | Kobayashi et al. | Oct 2013 | A1 |
20130284373 | Sun et al. | Oct 2013 | A1 |
20130284374 | Lubomirsky et al. | Oct 2013 | A1 |
20130286530 | Lin et al. | Oct 2013 | A1 |
20130295297 | Chou et al. | Nov 2013 | A1 |
20130298942 | Ren et al. | Nov 2013 | A1 |
20130302980 | Chandrashekar et al. | Nov 2013 | A1 |
20130337655 | Lee et al. | Dec 2013 | A1 |
20130343829 | Benedetti et al. | Dec 2013 | A1 |
20140004707 | Thedjoisworo et al. | Jan 2014 | A1 |
20140004708 | Thedjoisworo | Jan 2014 | A1 |
20140008880 | Miura et al. | Jan 2014 | A1 |
20140020708 | Kim et al. | Jan 2014 | A1 |
20140021673 | Chen et al. | Jan 2014 | A1 |
20140026813 | Wang et al. | Jan 2014 | A1 |
20140057447 | Yang et al. | Feb 2014 | A1 |
20140062285 | Chen | Mar 2014 | A1 |
20140065842 | Anthis et al. | Mar 2014 | A1 |
20140080308 | Chen et al. | Mar 2014 | A1 |
20140080309 | Park | Mar 2014 | A1 |
20140080310 | Chen et al. | Mar 2014 | A1 |
20140083362 | Lubomirsky et al. | Mar 2014 | A1 |
20140087488 | Nam et al. | Mar 2014 | A1 |
20140097270 | Liang et al. | Apr 2014 | A1 |
20140099794 | Ingle et al. | Apr 2014 | A1 |
20140124364 | Yoo et al. | May 2014 | A1 |
20140134847 | Seya | May 2014 | A1 |
20140141621 | Ren et al. | May 2014 | A1 |
20140147126 | Yamashita et al. | May 2014 | A1 |
20140152312 | Snow et al. | Jun 2014 | A1 |
20140154668 | Chou et al. | Jun 2014 | A1 |
20140165912 | Kao et al. | Jun 2014 | A1 |
20140166617 | Chen | Jun 2014 | A1 |
20140166618 | Tadigadapa et al. | Jun 2014 | A1 |
20140186772 | Pohlers et al. | Jul 2014 | A1 |
20140190410 | Kim | Jul 2014 | A1 |
20140191388 | Chen | Jul 2014 | A1 |
20140199851 | Nemani et al. | Jul 2014 | A1 |
20140209245 | Yamamoto et al. | Jul 2014 | A1 |
20140225504 | Kaneko et al. | Aug 2014 | A1 |
20140227881 | Lubomirsky et al. | Aug 2014 | A1 |
20140234466 | Gao et al. | Aug 2014 | A1 |
20140248773 | Tsai et al. | Sep 2014 | A1 |
20140248780 | Ingle et al. | Sep 2014 | A1 |
20140256131 | Wang et al. | Sep 2014 | A1 |
20140256145 | Abdallah et al. | Sep 2014 | A1 |
20140262031 | Belostotskiy et al. | Sep 2014 | A1 |
20140262038 | Wang et al. | Sep 2014 | A1 |
20140263172 | Xie et al. | Sep 2014 | A1 |
20140263272 | Duan et al. | Sep 2014 | A1 |
20140264533 | Simsek-Ege | Sep 2014 | A1 |
20140271097 | Wang et al. | Sep 2014 | A1 |
20140273373 | Makala et al. | Sep 2014 | A1 |
20140273406 | Wang et al. | Sep 2014 | A1 |
20140273451 | Wang et al. | Sep 2014 | A1 |
20140273462 | Simsek-Ege et al. | Sep 2014 | A1 |
20140273489 | Wang et al. | Sep 2014 | A1 |
20140273491 | Zhang et al. | Sep 2014 | A1 |
20140273492 | Anthis et al. | Sep 2014 | A1 |
20140273496 | Kao | Sep 2014 | A1 |
20140288528 | Py et al. | Sep 2014 | A1 |
20140302678 | Paterson et al. | Oct 2014 | A1 |
20140302680 | Singh | Oct 2014 | A1 |
20140308758 | Nemani et al. | Oct 2014 | A1 |
20140308816 | Wang et al. | Oct 2014 | A1 |
20140311581 | Belostotskiy et al. | Oct 2014 | A1 |
20140342532 | Zhu | Nov 2014 | A1 |
20140342569 | Zhu et al. | Nov 2014 | A1 |
20140349477 | Chandrashekar et al. | Nov 2014 | A1 |
20140357083 | Ling et al. | Dec 2014 | A1 |
20140361684 | Ikeda et al. | Dec 2014 | A1 |
20150011096 | Chandrasekharan et al. | Jan 2015 | A1 |
20150014152 | Hoinkis et al. | Jan 2015 | A1 |
20150031211 | Sapre et al. | Jan 2015 | A1 |
20150037980 | Rha | Feb 2015 | A1 |
20150060265 | Cho et al. | Mar 2015 | A1 |
20150076110 | Wu et al. | Mar 2015 | A1 |
20150076586 | Rabkin et al. | Mar 2015 | A1 |
20150079797 | Chen et al. | Mar 2015 | A1 |
20150118858 | Takaba | Apr 2015 | A1 |
20150126035 | Diao et al. | May 2015 | A1 |
20150126039 | Korolik et al. | May 2015 | A1 |
20150126040 | Korolik et al. | May 2015 | A1 |
20150129541 | Wang et al. | May 2015 | A1 |
20150129545 | Ingle et al. | May 2015 | A1 |
20150129546 | Ingle et al. | May 2015 | A1 |
20150132953 | Nowling | May 2015 | A1 |
20150132968 | Ren et al. | May 2015 | A1 |
20150152072 | Cantat et al. | Jun 2015 | A1 |
20150155177 | Zhang et al. | Jun 2015 | A1 |
20150170879 | Nguyen et al. | Jun 2015 | A1 |
20150170920 | Purayath et al. | Jun 2015 | A1 |
20150170924 | Nguyen et al. | Jun 2015 | A1 |
20150170926 | Michalak | Jun 2015 | A1 |
20150170935 | Wang et al. | Jun 2015 | A1 |
20150170943 | Nguyen et al. | Jun 2015 | A1 |
20150171008 | Luo | Jun 2015 | A1 |
20150179464 | Wang et al. | Jun 2015 | A1 |
20150187625 | Busche et al. | Jul 2015 | A1 |
20150206764 | Wang et al. | Jul 2015 | A1 |
20150214066 | Luere et al. | Jul 2015 | A1 |
20150214067 | Zhang et al. | Jul 2015 | A1 |
20150214092 | Purayath et al. | Jul 2015 | A1 |
20150214337 | Ko et al. | Jul 2015 | A1 |
20150221541 | Nemani et al. | Aug 2015 | A1 |
20150235809 | Ito et al. | Aug 2015 | A1 |
20150235863 | Chen | Aug 2015 | A1 |
20150235865 | Wang et al. | Aug 2015 | A1 |
20150235867 | Nishizuka | Aug 2015 | A1 |
20150247231 | Nguyen et al. | Sep 2015 | A1 |
20150249018 | Park et al. | Sep 2015 | A1 |
20150270140 | Gupta et al. | Sep 2015 | A1 |
20150275361 | Lubomirsky et al. | Oct 2015 | A1 |
20150275375 | Kim et al. | Oct 2015 | A1 |
20150294980 | Lee et al. | Oct 2015 | A1 |
20150332930 | Wang et al. | Nov 2015 | A1 |
20150340225 | Kim et al. | Nov 2015 | A1 |
20150345029 | Wang et al. | Dec 2015 | A1 |
20150357201 | Chen et al. | Dec 2015 | A1 |
20150357205 | Wang et al. | Dec 2015 | A1 |
20150371861 | Li et al. | Dec 2015 | A1 |
20150371864 | Hsu et al. | Dec 2015 | A1 |
20150371865 | Chen et al. | Dec 2015 | A1 |
20150371866 | Chen et al. | Dec 2015 | A1 |
20150380431 | Kanamori et al. | Dec 2015 | A1 |
20160005572 | Liang et al. | Jan 2016 | A1 |
20160005833 | Collins et al. | Jan 2016 | A1 |
20160027654 | Kim et al. | Jan 2016 | A1 |
20160027673 | Wang et al. | Jan 2016 | A1 |
20160035586 | Purayath et al. | Feb 2016 | A1 |
20160035614 | Purayath et al. | Feb 2016 | A1 |
20160042968 | Purayath et al. | Feb 2016 | A1 |
20160056167 | Wang et al. | Feb 2016 | A1 |
20160064233 | Wang et al. | Mar 2016 | A1 |
20160079072 | Wang et al. | Mar 2016 | A1 |
20160086807 | Park et al. | Mar 2016 | A1 |
20160086808 | Zhang et al. | Mar 2016 | A1 |
20160086815 | Pandit et al. | Mar 2016 | A1 |
20160086816 | Wang et al. | Mar 2016 | A1 |
20160093505 | Chen et al. | Mar 2016 | A1 |
20160093506 | Chen et al. | Mar 2016 | A1 |
20160104606 | Park et al. | Apr 2016 | A1 |
20160118268 | Ingle et al. | Apr 2016 | A1 |
20160148821 | Singh et al. | May 2016 | A1 |
20160163512 | Lubomirsky | Jun 2016 | A1 |
20160163513 | Lubomirsky | Jun 2016 | A1 |
20160181112 | Xue et al. | Jun 2016 | A1 |
20160189933 | Kobayashi et al. | Jun 2016 | A1 |
20160204009 | Nguyen et al. | Jul 2016 | A1 |
20160218018 | Lieu et al. | Jul 2016 | A1 |
20160222522 | Wang et al. | Aug 2016 | A1 |
20160225651 | Tran et al. | Aug 2016 | A1 |
20160225652 | Tran et al. | Aug 2016 | A1 |
20160237570 | Tan et al. | Aug 2016 | A1 |
20160240389 | Zhang et al. | Aug 2016 | A1 |
20160240402 | Park et al. | Aug 2016 | A1 |
20160260588 | Park et al. | Sep 2016 | A1 |
20160260616 | Li et al. | Sep 2016 | A1 |
20160260619 | Zhang et al. | Sep 2016 | A1 |
20160284556 | Ingle et al. | Sep 2016 | A1 |
20160300694 | Yang et al. | Oct 2016 | A1 |
20170040175 | Xu et al. | Feb 2017 | A1 |
20170040190 | Benjaminson et al. | Feb 2017 | A1 |
20170040191 | Benjaminson et al. | Feb 2017 | A1 |
20170040207 | Purayath | Feb 2017 | A1 |
20170062184 | Tran et al. | Mar 2017 | A1 |
Number | Date | Country |
---|---|---|
1675160 | Jun 2006 | EP |
S59-126778 | Jul 1984 | JP |
H01-200627 | Aug 1989 | JP |
H02-114525 | Apr 1990 | JP |
H07-153739 | Jun 1995 | JP |
H8-31755 | Feb 1996 | JP |
H08-264510 | Oct 1996 | JP |
2003-174020 | Jun 2003 | JP |
2005-050908 | Feb 2005 | JP |
2010-180458 | Aug 2010 | JP |
4763293 | Aug 2011 | JP |
2012-19164 | Jan 2012 | JP |
2013-243418 | Dec 2013 | JP |
10-2000-008278 | Feb 2000 | KR |
2003-0023964 | Mar 2003 | KR |
100441297 | Jul 2004 | KR |
10-2005-0007143 | Jan 2005 | KR |
10-2005-0042701 | May 2005 | KR |
2005-0049903 | May 2005 | KR |
100712727 | Apr 2007 | KR |
2007-0079870 | Aug 2007 | KR |
10-2008-0063988 | Jul 2008 | KR |
10-2009-0128913 | Dec 2009 | KR |
10-2011-0086540 | Jul 2011 | KR |
10-2011-0126675 | Nov 2011 | KR |
10-2012-0082640 | Jul 2012 | KR |
2011-27983 | Aug 2011 | TW |
2012-07919 | Feb 2012 | TW |
2012-33842 | Aug 2012 | TW |
2008-112673 | Sep 2008 | WO |
2009-084194 | Jul 2009 | WO |
2010-010706 | Jan 2010 | WO |
2012-118987 | Sep 2012 | WO |
2012-125656 | Sep 2012 | WO |
Entry |
---|
Instrument Manual: Vacuum Gauge Model MM200, Rev D. TELEVAC (website: www.televac.com), A Division of the Fredericks Company, Huntingdon Valley, PA, US. 2008. pp. 162. |
H. Xiao, Introduction to Semiconductor Manufacturing Technology, published by Prentice Hall, 2001, ISBN 0-13-022404-9, pp. 354-356. |
Manual No. TQMA72E1. “Bayard-Alpert Pirani Gauge FRG-730: Short Operating Instructions” Mar. 2012. Agilent Technologies, Lexington, MA 02421, USA. pp. 1-45. |
International Search Report and Written Opinion of PCT/US2016/045551 mailed Nov. 17, 2016, all pages. |
International Search Report and Written Opinion of PCT/US2016/045543 mailed Nov. 17, 2016, all pages. |